TempP(1)

cont as TempP(2)

34165945 2006. Sotrovimab
34118007 2021. Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain.
34173969 2021. Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.
34179346 2021. Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach.
34179345 2021. Promising Immunotherapies against COVID-19.
34179347 2021. Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity.
34088885 2021. Revealing the therapeutic targets and molecular mechanisms of emodin-treated coronavirus disease 2019 via a systematic study of network pharmacology.
34182540 2021. Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis.
34165150 2021. Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.
34107027 2021. Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min.
34116850 2021. Letter to the editor regarding "The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients".
34181461 2021. Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes.
34145166 2021. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines.
34150012 2021. Study on clinical characteristics of 173 cases of COVID-19 and effect of glucocorticoid on nucleic acid negative conversion.
34181444 2021. Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.
34126030 2021. Obesity and Mortality Among Patients Diagnosed With COVID-19.
34126020 2021. Obesity and Mortality Among Patients Diagnosed With COVID-19.
34157321 2021. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo.
34112217 2021. Does methotrexate influence COVID-19 infection? Case series and mechanistic data.
34119826 2021. Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.
34110129 2021. Mechanism of Inhibition of the Reproduction of SARS-CoV-2 and Ebola Viruses by Remdesivir.
34153377 2021. Coronaviruses, cholesterol and statins: Involvement and application for Covid-19.
34163151 2021. Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach.
34158797 2021. Effect of Methylprednisolone on Inflammation and Coagulation in Patients with Severe COVID-19: A Retrospective Cohort Study.
34175563 2021. A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.
34119448 2021. Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation.
34126316 2021. Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19.
34126315 2021. Antiviral activities of flavonoids.
34124259 2021. Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2.
34144277 2021. Potential drug development and therapeutic approaches for clinical intervention in COVID-19.
34135261 2021. Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19.
34147082 2021. Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients.
34101232 2021. Cardiovascular drugs and COVID-19 clinical outcomes: A living systematic review and meta-analysis.
34166652 2021. TRP channels in COVID-19 disease: Potential targets for prevention and treatment.
34121836 2021. Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus.
34150913 2021. Virtual screenings of the bioactive constituents of tea, prickly chaff, catechu, lemon, black pepper, and synthetic compounds with the main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE 2) of SARS-CoV-2.
34133062 2021. Efficacy and safety of convalescent plasma therapy in SARS-CoV2 patients on hemodialysis.
34169913 2021. Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19.
34169911 2021. Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.
34169908 2021. Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors.
34128763 2021. Adjunctive treatment with high-titre convalescent plasma in severely and critically ill COVID-19 patients - a safe but futile intervention. A comparative cohort study.
34115314 2021. Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.
34163220 2021. Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India - A Hospital-Based Study.
34055243 2020. Confidentiality challenges surrounding plasma therapy during the COVID-19 pandemic: a case discussion in Iran.
34101207 2021. In-hospital mortality in SARS-CoV-2 stratified by serum 25-hydroxy-vitamin D levels: A retrospective study.
34181181 2021. Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.
34186495 2021. Potentials to alleviate coagulopathy and enhance microglial function of beta (beta)- glucans, making them worth a clinical study for COVID-19's neurological sequalae.
34147143 2021. Imatinib in COVID-19: hope and caution.
34147142 2021. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
34171382 2021. Zinc supplementation augments the suppressive effects of repurposed NF-kappaB inhibitors on ACE2 expression in human lung cell lines.
34154407 2021. Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides.
34159564 2021. Computational Lock and Key and Dynamic Trajectory Analysis of Natural Biophors Against COVID-19 Spike Protein to Identify Effective Lead Molecules.
34124934 2021. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
34139362 2021. Proteome Profiling of Recombinant DNase Therapy in Reducing NETs and Aiding Recovery in COVID-19 Patients.
34105049 2021. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
34117992 2021. Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study.
34135340 2021. Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers.
34131140 2021. Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease.
34141440 2021. Wide complex tachycardia in a patient with COVID-19 treated with chloroquine/azithromycin.
34122700 2021. Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report.
34128772 2021. Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials.
34142560 2021. Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.
34165771 2021. Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.
34114174 2021. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.
34128358 2021. Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data.
34128351 2021. p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein.
34174275 2021. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
34126419 2021. Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: A randomized controlled multicenter trial.
34185680 2021. Restriction of SARS-CoV-2 replication by targeting programmed -1 ribosomal frameshifting.
34186099 2021. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP).
34174559 2021. Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.
34114493 2021. Anticipated impact of stem cell and other cellular medicine clinical trials for COVID-19.
34124322 2021. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies.
34150487 2021. Molecular basis of quercetin as a plausible common denominator of macrophage-cholesterol-fenofibrate dependent potential COVID-19 treatment axis.
34168183 2021. Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19.
34127740 2021. Drug-drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain.
34127709 2021. Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry.
34112906 2021. Elovanoids downregulate SARS-CoV-2 cell-entry, canonical mediators and enhance protective signaling in human alveolar cells.
34112877 2021. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
34147798 2021. Occurrence and risk assessment of pharmaceuticals and personal care products (PPCPs) against COVID-19 in lakes and WWTP-river-estuary system in Wuhan, China.
34117216 2021. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy.
34112756 2021. Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1.
34127062 2021. Antiviral effects of ergosterol peroxide in a pig model of porcine deltacoronavirus (PDCoV) infection involves modulation of apoptosis and tight junction in the small intestine.
34107996 2021. Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives.
34104708 2021. Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: intersection between inflammation, mTOR pathway, autophagy and calorie restriction.
34179304 2021. In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors.
34066932 2021. Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective.
34117145 2021. A Global Early Empirical Therapy Randomized Study Design for Ivermectin in SARS-CoV-2 Infection.
34117141 2021. Colchicine Treatment in SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
34183281 2021. Evolucion del intervalo QTc en pacientes con infeccion SARS-CoV-2 tratados con farmacos antivirales.
34106173 2021. Hipervitaminosis D, alerta de precaucion. inverted question markIncremento asociado a pandemia Covid 19?. Reporte de 5 casos.
34126913 2021. Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application.
34126880 2021. Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects.
34184648 2021. Vitamin D in critical care: where are we now and what is next?
34109607 2021. Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy.
34109605 2021. Punicalagin and zinc (II) ions inhibit the activity of SARS-CoV-2 3CL-protease in vitro.
34109598 2021. Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations: from hyper-inflammation to cardiac dysfunctions.
34109586 2021. Trace elements and the carotid plaque: the GOOD (Mg, Zn, Se), the UGLY (Fe, Cu), and the BAD (P, Ca)?
34156699 2021. Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19.
34156698 2021. Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data.
34168039 2021. Targeting the m(6)A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication.
34128416 2021. Continuous hemadsorption with cytokine adsorber for severe COVID-19: A case series of 15 patients.
34182889 2021. In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2.
34182880 2021. Study of potentiality of dexamethasone and its derivatives against Covid-19.
34180374 2021. The novel tetrahydropyrimidine derivative as inhibitor of SARS CoV-2: synthesis, modeling and molecular docking analysis.
34151745 2021. Inhibitory activity of marine sponge metabolites on SARS-CoV-2 RNA dependent polymerase: virtual screening and molecular dynamics simulation.
34151735 2021. Computational study of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus.
34151733 2021. Screening of potential bio-molecules from Moringa olifera against SARS-CoV-2 main protease using computational approaches.
34121618 2021. Elucidation of the inhibitory activity of plant-derived SARS-CoV inhibitors and their potential as SARS-CoV-2 inhibitors.
34100886 2021. "Nanotraps" Designed to Capture and Clear SARS-CoV-2.
34145408 2020. Coronapod: Dexamethasone, the cheap steroid that could cut coronavirus deaths.
34131342 2020. Daily briefing: First drug shown to reduce deaths among people seriously ill with COVID-19.

34136758 2021. Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19.
34136757 2021. A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein Dynamics.
34164147 2021. Crystal structure and mol-ecular docking study of (E)-2-{[(E)-2-hy-droxy-5-methyl-benzyl-idene]hydrazinyl-idene}-1,2-di-phenyl-etha n-1-one.
34111867 2021. Ruxolitinib for Severe COVID-19-Related Hyperinflammation in Nonresponders to Steroids.
34181475 2021. Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.
34125594 2021. Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells.
34154830 2021. Quinacrine, an old drug with potential application as a treatment for novel coronavirus 2019-nCoV/SARSCoV-2 infection.
34136927 2021. An in vitro antiviral activity of iodine complexes against SARS-CoV-2.
34174588 2021. Altered expression of SARS-CoV-2 entry and processing genes by Porphyromonas gingivalis-derived lipopolysaccharide, inflammatory cytokines and prostaglandin E2 in human gingival fibroblasts.
34101801 2021. Efficient Identification of High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Plasma Samples by Pooling Method.
34122672 2021. Evidence-based traditional Siddha formulations for prophylaxis and management of respiratory symptoms in COVID-19 pandemic-a review.
34179514 2021. In silico investigation of pro-arrhythmic effects of azithromycin on the human ventricle.
34099985 2021. In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease.
34139879 2021. Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals.
34128459 2021. Antiviral and immunological activity of zinc and possible role in COVID-19.
34117734 2021. DeepR2cov: deep representation learning on heterogeneous drug networks to discover anti-inflammatory agents for COVID-19.
34169381 2021. RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.
34109302 2021. JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations.
34161776 2021. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
34180562 2021. miRNAs; a novel strategy for the treatment of COVID-19.
34171229 2021. Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis.
34174194 2021. An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M(pro) inhibitor.
34180719 2021. The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial.
34163622 2021. A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.
34123218 2020. Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning.
34094251 2020. Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors.
34163906 2020. Mechanism of inhibition of SARS-CoV-2 M(pro) by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.
34094317 2020. Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 M(pro) by QM/MM computational methods.
34142459 2021. In Silico Characterization of Masitinib Interaction with SARS-CoV-2 Main Protease.
34182791 2021. Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.
34160843 2021. Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis.
34139335 2021. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study.
34134915 2021. Evolution of the nutritional status of COVID-19 critically-ill patients: A prospective observational study from ICU admission to three months after ICU discharge.
34140163 2021. Nutritional management of individuals with obesity and COVID-19: ESPEN expert statements and practical guidance.
34134917 2021. Impact of nutritional therapy during the first wave of the COVID-19 pandemic in intensive care patients: A retrospective observational study.
34155055 2021. Bradycardie associee a un traitement au remdesivir contre la COVID-19 chez un homme de 59 ans.
34145052 2021. Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial.
34178542 2021. Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.
34178527 2021. Tocilizumab and Thromboembolism in COVID-19: A Retrospective Hospital-Based Cohort Analysis.
34178488 2021. Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids.
34135013 2021. Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.
34186344 2021. Steroid use during COVID-19 infection and hyperglycemia - What a physician should know.
34119679 2021. Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy.
34130375 2021. Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective.
34185269 2021. Italian and Japanese public attention toward balneotherapy in the COVID-19 era.
34185077 2021. Tocilizumab, blood cells, and mild COVID-19: delayed vascular protection by interleukin blockade?
34185313 2021. Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis.
34163017 2021. Nutrition and immunity: lessons for COVID-19.
34107055 2021. Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.
34158235 2021. Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma.
34118724 2021. Improved SARS-CoV-2 M(pro) inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies.
34147744 2021. Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors.
34179022 2021. Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19.
34177879 2021. Antibody Responses and the Effects of Clinical Drugs in COVID-19 Patients.
34149735 2021. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
34179035 2021. Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study.
34179030 2021. Effectiveness of Pre-procedural Mouth Rinses in Reducing Aerosol Contamination During Periodontal Prophylaxis: A Systematic Review.
34164419 2021. Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence.
34164411 2021. Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report.
34183274 2021. Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting.
34162159 2021. The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-gamma production in vitro.
34162133 2021. Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis.
34162130 2021. Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.
34160786 2021. Risk Perception, Self-efficacy, Lay Theories of Health, and Engagement in Health-Protective Behaviors Among Hospital Pharmacists During the COVID-19 Pandemic.
34111482 2021. A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2).
34118289 2021. Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides.
34131411 2021. Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study.
34135619 2021. Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study.
34175482 2021. Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
34174433 2021. The potential significance of vitamin D binding protein polymorphism in COVID-19.
34157385 2021. Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial.
34160563 2021. ACE2 Expression Is Upregulated in Inflammatory Corneal Epithelial Cells and Attenuated by Resveratrol.
34183961 2021. In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2.
34121671 2021. Low-dose radiotherapy for COVID 19: A radioimmunological perspective.
34173802 2021. Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.
34160093 2021. Recent advances in antibody-based immunotherapy strategies for COVID-19.
34159729 2021. Interplay between SARS-CoV-2-derived miRNAs, immune system, vitamin D pathway and respiratory system.
34124899 2021. Dynamic Profiling of beta-Coronavirus 3CL M(pro) Protease Ligand-Binding Sites.
34139758 2021. Vitamin D Deficiency Is Associated With Higher Hospitalization Risk From COVID-19: A Retrospective Case-control Study.
34157144 2021. Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy.
34124396 2021. Variances in BCG protection against COVID-19 mortality: A global assessment.
34178413 2021. COVID-19 rhapsody: Rage towards advanced diagnostics and therapeutic strategy.
34165239 2021. Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme.
34160253 2021. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
34133856 2021. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.
34158667 2021. 'Super-antibodies' could curb COVID-19 and help avert future pandemics.
34162861 2021. A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry.
34155214 2021. Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2.
34155207 2021. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals.
34107799 2021. Virtual screening, ADMET profiling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and flavonoids against COVID-19 main protease (M(pro)).
34112985 2021. Severe COVID-19 outcomes - the role of physical activity.
34131332 2021. 100 years of Bacillus Calmette-Guerin immunotherapy: from cattle to COVID-19.
34165650 2021. MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine.
34149314 2021. Vitamin D: What's new a year on from the COVID-19 outbreak?
34132561 2021. Vitamina D y su importancia en la infeccion por SARS-CoV-2.
34116393 2021. Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2).
34167880 2021. Vitamin D binding protein: A polymorphic protein with actin-binding capacity in COVID- 19.
34108344 2021. Treatment of COVID-19-Related Olfactory Disorder Promoted by Kakkontokasenkyushin'i: A Case Series.
34183901 2021. COVID-19, hydroxychloroquine and the importance of disease progression.
34147358 2021. COVID-19 antibody donation using immunoadsorption: Report of two cases.
34144875 2021. Ubiquitous convalescent plasma: An artificial universal plasma for COVID-19 patients.
34172379 2021. COVID-19 convalescent plasma therapy for immunodeficient patients-weighing up risks and benefits.
34175469 2021. A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis.
34116917 2021. COVID-19 convalescent plasma therapy and immunodeficiency.
34112359 2021. Selenium.
34137279 2021. Potential Dexamethasone-Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID?
34162596 2021. Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study by Klopfenstein et al.
34162593 2021. Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'.
34116544 2021. The impact of atherosclerotic cardiovascular disease, dyslipidaemia and lipid lowering therapy on Coronavirus disease 2019 outcomes: an examination of the available evidence.
34102962 2021. The roles of vitamin D in increas-ing the body's immunity and reducing injuries due to viral infections: With an emphasis on its possible role in SARS-CoV-2 (COVID-19).
34140674 2021. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19.
34127864 2021. A white-knuckle ride of open COVID drug discovery.

34182016 2021. Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.
34112355 2021. Zinc.
34180141 2021. Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.
34179893 2021. mTOR: A possible therapeutic target against SARS-CoV-2 infection.
34152629 2021. Blood purification with CytoSorb in critically ill COVID-19 patients: A case series of 26 patients.
34136234 2021. Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus.
34179567 2021. An approach towards COVID-19 pandemic with Yoga and Naturopathy interventions- Tamilnadu model.
34181716 2021. Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
34166513 2021. Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.
34111274 2021. Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study.
34111237 2021. The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection.
34113086 2021. Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study.
34134916 2021. Hypozincemia in the early stage of COVID-19 is associated with an increased risk of severe COVID-19.
34139028 2021. Heterogeneity in COVID-19 Convalescent Plasma Clinical Trials.
34121337 2021. Immune-viral dynamics modeling for SARS-CoV-2 drug development.
34153446 2021. A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19).
34116362 2021. Interaction of selected terpenoids with two SARS-CoV-2 key therapeutic targets: An in silico study through molecular docking and dynamics simulations.
34174757 2021. Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation.
34147856 2021. Rational optimization of a human neutralizing antibody of SARS-CoV-2.
34151773 2021. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice.
34114951 2021. Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection.
34170074 2021. Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin.
34126092 2021. Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.
34111397 2021. Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors "leflunomide" and "teriflunomide" in Covid-19: A narrative review.
34148335 2021. Evaluate the Therapeutic Effect of Allicin (L-cysteine) on Clinical Presentation and Prognosis in Patients with COVID-19.
34172918 2021. Could certain mouthwashes reduce transmissibility of COVID-19?
34177405 2021. Margins of beneficial daily dosage of supplements in prevention of COVID-19.
34162299 2021. Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database.
34123871 2021. Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants.
34177967 2021. Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcgammaRIIA and FcalphaRI.
34136511 2021. Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2.
34177827 2021. Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study.
34179095 2021. In-Silico Evidence for a Two Receptor Based Strategy of SARS-CoV-2.
34179072 2021. A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials.
34136533 2021. Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection.
34124140 2021. Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach.
34179059 2021. Probiotics as Adjunctive Treatment for Patients Contracted COVID-19: Current Understanding and Future Needs.
34150833 2021. Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity.
34150825 2021. Socio-Demographic and Knowledge-Related Determinants of Vitamin D Supplementation in the Context of the COVID-19 Pandemic: Assessment of an Educational Intervention.
34178891 2021. Efficacy of CytoSorb in a Pediatric Case of Severe Multisystem Infammatory Syndrome (MIS-C): A Clinical Case Report.
34177566 2021. Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2.
34163359 2021. Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.
34149420 2021. Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City.
34122096 2021. Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions.
34122093 2021. Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis-Manifested Severe Disease.
34122090 2021. Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial.
34122073 2021. The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19.
34122058 2021. Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents.
34127895 2021. Prediction of remdesivir resistance in COVID-19 illness: Need for development of clinical laboratory test.
34121921 2021. The supramolecularly complexes of calix[4]arene derivatives toward favipiravir antiviral drug (used to treatment of COVID-19): a DFT study on the geometry optimization, electronic structure and infrared spectroscopy of adsorption and sensing.
34158240 2021. Response to: Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
34120824 2021. Tocilizumab in COVID-19: The Cerrahpasa-PREDICT score.
34153099 2021. Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial.
34111271 2021. Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
34153729 2021. Intravenous methylprednisolone with or without tocilizumab in patients with severe COVID-19 pneumonia requiring oxygen support: A prospective comparison.
34153727 2021. Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes.
34153723 2021. Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
34154967 2021. Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care.
34107241 2021. Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions.
34114829 2021. Targeting SARS-CoV-2 Receptor Binding Domain with Stapled Peptides: An In Silico Study.
34106748 2021. N-(4-Hydroxyphenyl) Retinamide Suppresses SARS-CoV-2 Spike Protein-Mediated Cell-Cell Fusion by a Dihydroceramide Delta4-Desaturase 1-Independent Mechanism.
34124324 2021. Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection.
34137799 2021. Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.
34147248 2021. Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia.
34103164 2021. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia.
34109277 2021. Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection.
34169042 2021. Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial.
34172984 2020. Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.
34102808 2021. Corticosteroids in patients with COVID-19: use and misuse.
34102804 2021. Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients.
34180638 2021. Pycnogenol(R)-Centellicum(R) supplementation improves lung fibrosis and Post-Covid-19 lung healing.
34121379 2021. Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma.
34131556 2021. Molecular docking and dynamics studies of curcumin with COVID-19 proteins.
34132421 2021. Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs.
34132429 2021. Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review.
34181666 2021. Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.
34166458 2021. The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.
34161386 2021. The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody.
34143818 2021. An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.
34138966 2021. Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions.
34138909 2021. Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda.
34115801 2021. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
34115763 2021. Ayurveda botanicals in COVID-19 management: An in silico multi-target approach.
34157054 2021. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing.
34138976 2021. Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection.
34180610 2021. Should we supplement zinc in COVID-19 patients? Evidence from a meta-analysis.
34136717 2021. Old drugs for a new indication: a review of chloroquine and analogue in COVID-19 treatment.
34185762 2021. Could Lithium Be a New Hope in COVID-19 Treatment? A Case Report.
34154977 2021. Steroid resistance and rebound phenomena in patients with COVID-19.
34153704 2021. Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials.
34173692 2021. Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.
34177317 2021. Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients - A narrative review and hypotheses.
34127903 2021. Potential natural candidates in the treatment of coronavirus infections.
34164838 2021. Prospective individual patient data meta-analysis: Evaluating convalescent plasma for COVID-19.
34164948 2021. Inflammation, a common mechanism in frailty and COVID-19, and stem cells as a therapeutic approach.
34161756 2021. Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.
34121205 2021. SARS-CoV-2 antibody persistence in COVID-19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance.
34173248 2021. COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.
34180156 2021. A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?
34110032 2021. Potential use of serum-derived bovine immunoglobulin/protein isolate for the management of COVID-19.
34157110 2021. Accelerating the Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: A Risk of Combining Dexamethasone and Tocilizumab for Severe Coronavirus Disease 2019.
34181630 2021. An EUA for sotrovimab for treatment of COVID-19.
34098020 2021. 1,25-Dihydroxyvitamin D3 inhibits porcine epidemic diarrhea virus replication by regulating cell cycle resumption in IPEC-J2 porcine epithelial cells.
34153975 2021. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
34171927 2021. Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases.
34131980 2021. A comprehensive review of the therapeutic potential of curcumin nanoformulations.
34175754 2021. Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids.
34142159 2021. Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
34105505 2021. [Therapeutic Effect of Convalescent Plasma Transfusion on Fulminant Viral Infectious Diseases--Review].
34105503 2021. [Bioinformatics Analysis of the Influence of Coronavirus Infection on Hematopoietic System and Potential Intervention Drugs and Their Significance for COVID-19].
34053480 2021. [Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].

34152728 2021. The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors.
34129317 2021. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.
34138478 2021. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial.
34176789 2021. Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease.
34168096 2021. In silico analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients.
34118024 2021. Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review.
34166653 2021. Low Serum Levels of 25-Hydroxyvitamin D Accompany Severe COVID-19 Because it is a Negative Acute Phase Reactant.
34125578 2021. Update Alert: Remdesivir for Adults With COVID-19.
34180274 2021. Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
34099486 2021. Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals.
34104872 2021. Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy.
34097986 2021. What do secreted phospholipases A2 have to offer in combat against different viruses up to SARS-CoV-2?
34126960 2021. Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.
34183316 2021. Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab.
34168031 2021. Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis.
34148292 2021. Fragment-based in silico design of SARS-CoV-2 main protease inhibitors.
34145723 2021. From Cancer to COVID-19: A Perspective on Targeting Heparan Sulfate-Protein Interactions.
34131543 2021. Evolution of COVID-19 Pregnancies Treated With Nitazoxanide in a Third-Level Hospital.
34149296 2021. Surfactants - Compounds for inactivation of SARS-CoV-2 and other enveloped viruses.
34112047 2021. Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy.
34148582 2021. Coronavirus disease 2019 vaccination in women seeking pregnancy or in early pregnancy: What is there to debate?
34160789 2021. Micronutrient therapy and effective immune response: a promising approach for management of COVID-19.
34173853 2021. How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1alpha.
34185200 2021. Shedding light on vitamin D: the shared mechanistic and pathophysiological role between hypovitaminosis D and COVID-19 risk factors and complications.
34110533 2021. Role of vitamins and minerals as immunity boosters in COVID-19.
34132052 2021. Systemic steroids may enhance recovery from loss of smell and taste in hospitalized coronavirus disease 2019 (COVID-19) patients: an observational study.
34186281 2021. CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial.
34153671 2021. A single center experience of intravenous immunoglobulin treatment in Covid-19.
34147912 2021. Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial.
34107137 2021. Impact of intermediate to high doses of methylprednisolone on mortality rate in patients with COVID-19 pneumonia-induced severe systemic inflammation.
34185352 2021. Drug-induced QTc interval prolongation in PCR-positive non-ICU COVID-19 patients with diverse findings on chest computed tomography.
34118111 2021. Use of aspirin in reduction of mortality of COVID-19 patients: A meta-analysis.
34159128 2021. What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness.
34139368 2021. Vigilance in selection of low-dose versus high-dose steroids in COVID-19.
34163159 2021. Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19.
34158414 2021. Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence.
34183914 2021. Latest Effective Measures to Combat COVID-19: A Review.
34159141 2021. Structure-based virtual screening of bioactive compounds from Indonesian medical plants against severe acute respiratory syndrome coronavirus-2.
34144110 2021. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
34120854 2021. Vitamin C and zinc lozenges for COVID-19?
34112616 2021. Re: Vitamin C and zinc lozenges for COVID-19?
34103847 2021. Magnesium: The neglected cation in COVID-19?
34169361 2021. Glucose control using an artificial pancreas in a severe COVID-19 patient on extracorporeal membrane oxygenation: a case report.
34127807 2021. RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article.
34149233 2021. Portrayal of status of AYUSH clinical studies for COVID-19: A CTRI perspective.
34127896 2021. A Pilot Clinical study of an add on Ayurvedic formulation containing Guduchi and Pippali in mild to moderate Covid - 19.
34118236 2021. Decoding molnupiravir-induced mutagenesis in SARS-CoV-2.
34104664 2021. Virtual screening on the web for drug repurposing: a primer.
34155961 2021. Integrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors.
34089793 2021. Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection.
34175365 2021. Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.
34146463 2021. Bilateral foot ulcers in a COVID-19 patient under favipiravir treatment.
34139069 2021. Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.
34148009 2021. Hemoadsorption in critically ill patients with or without COVID-19: A word of caution.
34127930 2021. Nanotherapeutics for treating coronavirus diseases.
34165766 2021. Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis.
34174375 2021. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.
34145521 2021. Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis.
34101851 2021. Interferon-alpha position in combating with COVID-19: A systematic review.
34119951 2021. Examining the interactions scorpion venom peptides (HP1090, Meucin-13, and Meucin-18) with the receptor binding domain of the coronavirus spike protein to design a mutated therapeutic peptide.
34169390 2021. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
34132436 2021. Identification of Severe Acute Respiratory Syndrome Coronavirus-2 inhibitors through in silico structure-based virtual screening and molecular interaction studies.
34149064 2021. COVID-19 and Ivermectin: Potential threats associated with human use.
34149065 2021. COVID-19: In silico identification of potent alpha-ketoamide inhibitors targeting the main protease of the SARS-CoV-2.
34112203 2021. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19.
34121824 2021. Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies.
34144245 2021. Could treatment with botulinum toxin protect against subsequent infection with COVID-19?
34167924 2021. Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic.
34147258 2021. Chez les sujets hospitalises pour COVID-19 avec hypoxemie et inflammation systemique, est-ce que le tocilizumab diminue la mortalite a 28jours comparativement au traitement standard tout en etant securitaire ?
34133812 2021. The effects of orally administered lactoferrin in the prevention and management of viral infections: A systematic review.
34149273 2021. A Mini Review on Discovery and Synthesis of Remdesivir as an Effective and Promising Drug against COVID-19.
34155432 2021. New Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Zn(II), Cd(II), and Hg(II) Gibberellate Complexes: Synthesis, Structure, and Inhibitory Activity Against COVID-19 Protease.
34135666 2021. Prevalence of using herbs and natural products as a protective measure during the COVID-19 pandemic among the Saudi population: an online cross-sectional survey.
34134991 2021. Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity.
34140611 2021. ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea.
34140558 2021. An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants.
34104394 2021. Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection.
34116915 2021. Covid-19 convalescent plasma and SARS-CoV-2 viral variants.
34177417 2021. Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.
34096059 2021. How we secured a COVID-19 convalescent plasma procurement scheme in Japan.
34165273 2021. Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19.
34141770 2021. Thymosin as a possible therapeutic drug for COVID-19: A case report.
34136074 2021. Different kinds of stem cells in the development of SARS-CoV-2 treatments.
34164296 2021. Medical nutritional therapy for renal transplantation in the COVID-19 pandemic.
34079693 2021. Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths: An ecological integrative approach.
34097101 2021. Colchicin: altes Medikament mit neuem Nutzen : Einsatz in der Rheumatologie und daruber hinaus.
34159380 2021. Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins.
34130467 2021. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
34107858 2021. Traditional Chinese Medicine Decoctions Significantly Reduce the Mortality in Severe and Critically Ill Patients with COVID-19: A Retrospective Cohort Study.
34143588 2021. The effect of SARS-CoV-2 effective mouthwashes on the staining, translucency and surface roughness of a nanofill resin composite.
34183586 2021. Famotidine and Hospitalized COVID-19 Patients: Are the Benefits True?
34142533 2021. Razrabotka protivovirusnykh lekarstv na osnove ingibitorov glavnoi proteazy SARS-CoV-2.
34142531 2021. Peptidnye ingibitory vzaimodeistviia retseptor-sviazyvaiushchego domena virusa SARS-CoV-2 s kletochnym retseptorom ASE2.
34139325 2021. Development of potent and selective Cathepsin C inhibitors free of aortic binding liability by application of a conformational restriction strategy.
34103299 2021. Covid-19: Aspirin does not improve survival for patients admitted to hospital, trial reports.
34140312 2021. Covid-19: Regeneron's antibody combination cuts deaths in seronegative patients, trial finds.
34172507 2021. Dimethyl fumarate for COVID-19.
34161118 2021. Determination of inhibitor activity of drugs against the COVID-19.
34180984 2021. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein.
34134587 2021. Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma.
34143707 2021. The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases.
34167431 2021. Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes.
34182881 2021. N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study.
34155472 2021. The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece.
34132188 2021. Hypothesis: Designation of Liposomal Scavenger System for Fighting against 2019-nCoV.
34097474 2021. Short-Chain Fatty Acids as a Potential Treatment for Infections: a Closer Look at the Lungs.
34100300 2021. Immunomodulatory role and potential utility of various nutrients and dietary components in SARS-CoV-2 infection.
34152840 2021. The Potential Role of Aerosolized Phosphodiesterase 3 Inhibitor Enoximone in the Management of Coronavirus Disease 2019 Hypoxemia: A Case Report.
34115941 2021. The Association of Inhaled Corticosteroid Before Admission and Survival of Patients with COVID-19.
34142123 2021. Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?
34165438 2021. Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes.
34148541 2021. Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi").

34341772 2021. Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay.
34339171 2021. Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent Model.
34408808 2021. Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency.
34394844 2021. Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein.
34436866 2021. Metal-Mediated Nanoscale Cerium Oxide Inactivates Human Coronavirus and Rhinovirus by Surface Disruption.
34368522 2021. Evolution of the Synthesis of Remdesivir. Classical Approaches and Most Recent Advances.
34414360 2021. Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir.
34396059 2021. Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein.
34406642 2021. Vitamin D supplementation and COVID-19 disease: safety but unproven efficacy-reply to Dr Helga Rhein.
34387839 2021. Vitamin D and COVID-19 disease: don't believe everything you read in the papers! Reply to Dr William B. Grant.
34341950 2021. Vitamin D and coronavirus disease 2019 (COVID-19)-rapid evidence review.
34341700 2021. Polyphenols Could Prevent SARS-CoV-2 Infection by Modulating the Expression of miRNAs in the Host Cells.
34308111 2021. No evidence that vitamin D is able to prevent or affect the severity of COVID-19 in individuals with European ancestry: a Mendelian randomisation study of open data.
34218906 2021. Improved oxygenation with inhaled milrinone in mechanically ventilated patients with severe COVID-19.
34099015 2021. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19.
34147855 2021. Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant.
34144270 2021. A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2.
34109016 2021. Interaction of 8-anilinonaphthalene-1-sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification.
34104357 2021. Screening of world approved drugs against highly dynamical spike glycoprotein of SARS-CoV-2 using CaverDock and machine learning.
34123627 2021. Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient.
34131531 2021. Treatment With Remdesivir in Two Pregnant Patients With COVID-19 Pneumonia.
34121561 2021. Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice.
34152583 2021. Potential for the Repurposing of Adamantane Antivirals for COVID-19.
34183871 2021. Potent inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 by photosensitizers compounds.
34109306 2021. Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial.
34104878 2021. Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries.
34179737 2021. Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.
34172464 2021. Steroid use in elderly critically ill COVID-19 patients.
34177306 2021. Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients.
34177305 2021. COVID-19 and Cannabis: Playing Saint or Devil?
34177303 2021. Alternative Treatment Method for Novel Coronavirus Disease 2019: Coupled Plasma Filtration Adsorption.
34177298 2021. Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19.
34136130 2021. Association between convalescent plasma and the risk of mortality among patients with COVID-19: a meta-analysis.
34185437 2021. Targeting neuropilins as a viable SARS-CoV-2 treatment.
34118347 2021. Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective.
34173934 2021. Inactivation of SARS-CoV-2 by Ozonated Glycerol.
34149679 2021. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.
34140949 2021. Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A Case Report.
34122456 2021. Prospects of Neutralizing Nanobodies Against SARS-CoV-2.
34054806 2021. Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19.
34169728 2021. Rapid structure-based identification of potential SARS-CoV-2 main protease inhibitors.
34169729 2021. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening.
34141446 2021. Could Nanotheranostics be the Answer to the Coronavirus Crisis?
34131372 2021. Secretome of Multipotent Mesenchymal Stromal Cells as a Promising Treatment and for Rehabilitation of Patients with the Novel Coronaviral Infection.
34142164 2021. Stellungnahme zum Einsatz von topisch-inhalativem Budesonid bei COVID-19-Infektion : Positionspapier des Arzteverbands Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft fur Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie (DGHNO-KHC).
34153179 2021. A novel anti-inflammatory treatment for bradykinin-induced sore throat or pharyngitis.
34115964 2021. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation.
34273515 2021. Tocilizumab and Systemic Corticosteroids in the Management of Patients with COVID-19: A Systematic Review and Meta-Analysis.
34203261 2021. Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles.
34206794 2021. De novo ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation.
34201817 2021. Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems.
34201797 2021. Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
34198792 2021. Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis.
34209237 2021. Hydroxychloroquine and Azithromycin Treatment of Hospitalized Patients Infected with SARS-CoV-2 in Senegal from March to October 2020.
34232520 2021. Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study.
34228355 2021. Investigation of plasma exchange and hemoperfusion effects and complications for the treatment of patients with severe COVID-19 (SARS-CoV-2) disease: A systematic scoping review.
34196421 2021. Immunostimulation with interferon-gamma in protracted SARS-CoV-2 pneumonia.
34273116 2021. Dexamethasone treatment may mitigate adverse effects of vitamin D deficiency in hospitalized Covid-19 patients.
34255369 2021. Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients.
34294593 2021. Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis.
34329642 2021. Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations.
34237666 2021. Multifunctional inhibitors of SARS-CoV-2 by MM/PBSA, essential dynamics, and molecular dynamic investigations.
34311260 2021. Transcription factor NF-kappaB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model.
34305216 2021. Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2.
34236527 2021. Potential activity of Linezolid against SARS-CoV-2 using electronic and molecular docking study.
34236507 2021. Luteolin: a blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics.
34188314 2021. Synthesis and characterization of new thiazole-based Co(II) and Cu(II) complexes; therapeutic function of thiazole towards COVID-19 in comparing to current antivirals in treatment protocol.
34248201 2021. Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study.
34219808 2021. 3CL(pro) and PL(pro) affinity, a docking study to fight COVID19 based on 900 compounds from PubChem and literature. Are there new drugs to be found?
34316082 2021. The iron(III) and nickel(II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2.
34305175 2021. Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation.
34305174 2021. Seq12, Seq12m, and Seq13m, peptide analogues of the spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico study through molecular docking, molecular dynamics simulation, and MM-PB/GBSA calculations.
34305173 2021. Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain.
34278371 2021. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany.
34209064 2021. Antimicrobial Peptides and Physical Activity: A Great Hope against COVID 19.
34249143 2021. TiO2 supported single Ag atoms nanozyme for elimination of SARS-CoV2.
34244522 2021. Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.
34234131 2021. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.
34169568 2021. Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.
34114781 2021. Dietary recommendations during the Covid-19 pandemic. Statement of the Committee of Human Nutrition Science of the Polish Academy of Sciences.
34226623 2021. UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins.
34326429 2021. Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 M(PRO).
34315976 2021. Determination of the characteristic inactivation fluence for SARS-CoV-2 under UV-C radiation considering light absorption in culture media.
34315945 2021. Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics.
34306796 2021. The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on "Profibrotic Cytokine" IL-1beta Levels in Severe and Critical COVID-19 Patients: A Preliminary Study.
34192224 2021. COVID-19 and conjunctivitis: a meta-analysis.
34290856 2021. Vitamin D in the time of the coronavirus (COVID-19) pandemic - a clinical review from a public health and public mental health perspective.
34190621 2021. Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis.
34251081 2021. Convalescent plasma treatment for early post-kidney transplant acquired COVID-19.
34265436 2021. Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.
34256512 2021. COVID-19 pnomonisinde kortikosteroid kullanimi.
34200951 2021. SARS-CoV-2 Genetic Variability and Non-Specific Immunity Associated with the Use of Different BCG Strains-A Molecular and Clinical Approach.
34224110 2021. Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.
34224330 2021. Modulating the host immune response to fight against COVID-19: Where are we in 2021?
34189187 2021. Efficacy of phytochemicals as immunomodulators in managing COVID-19: a comprehensive view.
34189186 2021. Why Is Hormone Therapy Successful Strategy Against Coronavirus-19?
34307771 2021. Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach.
34226871 2021. Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (M(pro)).
34205217 2021. Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome.
34209556 2021. Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1.
34199134 2021. Effect of Aprotinin and Avifavir((R)) Combination Therapy for Moderate COVID-19 Patients.
34202029 2021. A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner.
34125976 2021. Qualifying coronavirus disease 2019 convalescent plasma donors in Israel.
34152842 2021. Acute Pain Crisis Caused by Tramadol Remdesivir Drug-Drug Interaction.
34173663 2021. Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.
34098784 2021. Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection.
34139040 2021. Melatonin and other indoles show antiviral activities against swine coronaviruses in vitro at pharmacological concentrations.
34128446 2021. Protective role of physical activity patterns prior to COVID-19 confinement with the severity/duration of respiratory pathologies consistent with COVID-19 symptoms in Spanish populations.
34148692 2021. Impacto de la terapia con corticoides en la supervivencia de los pacientes criticos con COVID-19 ingresados en una unidad de cuidados intensivos.
34160931 2021. Assurer un statut satisfaisant en vitamine D dans la population generale est particulierement important dans le contexte de la Covid-19.
34151629 2021. High-Throughput Affinity Selection Mass Spectrometry Using SAMDI-MS to Identify Small-Molecule Binders of the Human Rhinovirus 3C Protease.
34172713 2021. In silico screening of Allium cepa phytochemicals for their binding abilities to SARS and SARS-CoV-2 3C-like protease and COVID-19 human receptor ACE-2.

34283490 2021. Casirivimab
34283469 2021. Etesevimab
34283431 2021. Imdevimab
34437834 2021. Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19.
34453934 2021. Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: initial report.
34399060 2021. Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
34258083 2021. Vitamin D Toxicity Managed with Peritoneal Dialysis.
34238357 2021. A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.
34315862 2021. Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries.
34285198 2021. hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants.
34285195 2021. Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants.
34301923 2020. Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro.
34265246 2021. SnapShot: SARS-CoV-2 antibodies.
34192518 2021. Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.
34217004 2021. An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19.
34282298 2021. Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19.
34273271 2021. A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.
34270918 2021. Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy.
34237284 2021. Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19.
34200372 2021. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
34204163 2021. Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome.
34203435 2021. Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.
34222718 2021. The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review.
34325068 2021. Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy?
34242804 2021. Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicentre study (BACTCOVID).
34193235 2021. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
34289888 2021. Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome.
34271956 2021. Impact of dexamethasone use to prevent from severe COVID-19-induced acute kidney injury.
34291223 2021. Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia.
34277310 2021. The Use of Single Therapy With Tocilizumab Versus Combination Therapy With Remdesivir and Tocilizumab in SARS-CoV-2 Patients in El Paso, Texas.
34210790 2021. A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19.
34326192 2021. Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19.
34244316 2021. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.
34274135 2021. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy.
34240697 2021. SARS-CoV-2 neutralising antibody testing in Europe: towards harmo" width="940" height="350" frameborder="0" scrolling="auto"> tion of neutralising antibody titres for better use of convalescent plasma and comparability of trial data.
34249101 2021. A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.
34305892 2021. Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis.
34282358 2021. Targeting TLR4 Signaling to Blunt Viral-Mediated Acute Lung Injury.
34276706 2021. Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
34262564 2021. Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.
34262553 2021. Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications.
34248990 2021. Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19.
34248936 2021. A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.
34234774 2021. Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey.
34220861 2021. Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2.
34307417 2021. Case Report: Human Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Intervention for a Critically Ill COVID-19 Patient.
34277653 2021. Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19.
34250834 2021. The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.
34325042 2021. A five-day course of ivermectin may reduce the duration of COVID-19 illness.
34302964 2021. BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals.
34216737 2021. Evaluation of potassium peroxymonosulfate (MPS) efficacy against SARS-CoV-2 virus using RT-qPCR-based method.
34303433 2021. Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
34329624 2021. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
34252379 2021. Azithromycin: can its benefit be ruled out in mild COVID-19?
34252378 2021. Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial.
34285642 2021. Analysis of Available Nutrition Recommendations to Combat COVID-19: A Scoping Review.
34249616 2021. A New Drug Formula for Pneumonia and Severe Seasonal Flu; a Promising Drug for Eradicate COVID19.
34200055 2021. Protective Action of L. salivarius SGL03 and Lactoferrin against COVID-19 Infections in Human Nasopharynx.
34300711 2021. Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19.
34243954 2021. Tocilizumab therapy in SARS-CoV-2 pneumonia: A matched retrospective cohort analysis.
34213728 2021. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
34241772 2021. Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19.
34247339 2021. Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.
34282264 2021. Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties.
34282263 2021. Can antidepressants unlock prescription of rimonabant in the fight against COVID-19?
34191894 2020. Conformational fingerprints in the modelling performance of MIA-QSAR: a case for SARS-CoV protease inhibitors.
34200418 2021. Development of a Promising Method for Producing Oligomeric Mixture of Branched Alkylene Guanidines to Improve Substance Quality and Evaluate Their Antiviral Activity against SARS-CoV-2.
34200204 2021. Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues.
34322232 2021. Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy.
34260849 2021. Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
34322937 2021. Traditional medicines prescribed for prevention of COVID-19: Use with caution.
34254465 2021. SSRIs: Applications in inflammatory lung disease and implications for COVID-19.
34249367 2021. Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients.
34243781 2021. COVID-19: Up to 82% critically ill patients had low Vitamin C values.
34284268 2021. Potential molecular mechanisms of zinc- and copper-mediated antiviral activity on COVID-19.
34207901 2021. The Impact of COVID-19 Pandemic during 2020-2021 on the Vitamin D Serum Levels in the Paediatric Population in Warsaw, Poland.
34207873 2021. Bad Prognosis in Critical Ill Patients with COVID-19 during Short-Term ICU Stay regarding Vitamin D Levels.
34207745 2021. The Association of Low Vitamin K Status with Mortality in a Cohort of 138 Hospitalized Patients with COVID-19.
34204893 2021. Adherence to COVID-19 Nutrition Guidelines Is Associated with Better Nutritional Management Behaviors of Hospitalized COVID-19 Patients.
34203190 2021. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D.
34202697 2021. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis.
34202578 2021. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial.
34291118 2021. Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants.
34282406 2021. Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality.
34277887 2021. Effect of Monoclonal Antibody Treatment on Clinical Outcomes in Ambulatory Patients With Coronavirus Disease 2019.
34258324 2021. The Efficacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting.
34258319 2021. Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients.
34258316 2021. Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
34250192 2021. Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
34240839 2021. Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia?
34201131 2021. Rapid Inactivation In Vitro of SARS-CoV-2 in Saliva by Black Tea and Green Tea.
34198820 2021. Epitope-Specific Response of Human Milk Immunoglobulins in COVID-19 Recovered Women.
34199734 2021. Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study.
34202835 2021. Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry.
34293006 2021. Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.
34270554 2021. Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies.
34264974 2021. Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.
34221065 2021. Depinar, a drug that potentially inhibits the binding and entry of COVID-19 into host cells based on computer-aided studies.
34260977 2021. Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.
34230209 2021. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
34302737 2021. Effects of Androgen Deprivation Therapy on COVID-19 in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis.
34187707 2021. Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
34311073 2021. The potential role of thymoquinone in preventing the cardiovascular complications of COVID-19.
34238341 2021. Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study.
34301275 2021. Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics.
34256791 2021. Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report.
34202565 2021. The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2.
34201591 2021. Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.
34206468 2021. Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review.
34330173 2021. Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
34330160 2021. Comment: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
34417168 2021. Covid-19: UK approves first monoclonal antibody treatment.

34188665 2021. Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera.
34321065 2021. Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review.
34315521 2021. Current status of traditional Chinese medicine for the treatment of COVID-19 in China.
34265054 2021. Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.
34306990 2021. Preliminary investigation of drug impurities associated with the anti-influenza drug Favipiravir - An insilico approach.
34218521 2021. Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.
34292670 2021. Population pharmacokinetics of favipiravir in patients with COVID-19.
34237554 2021. Ivermectin and mortality in patients with COVID-19: A systematic review, meta-analysis, and meta-regression of randomized controlled trials.
34217144 2021. "Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis".
34215019 2021. Pharmacokinetic profiles of a SARS-COV-2 neutralizing antibody BD-604 in cynomolgus monkeys.
34324175 2021. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
34189446 2021. Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial.
34222849 2021. Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial.
34274837 2021. Nano-biofortification of different crops to immune against COVID-19: A review.
34302370 2021. Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies.
34278967 2021. Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants.
34272669 2021. The contribution of bovines to human health against viral infections.
34302132 2021. The effect of high-dose parenteral vitamin D3 on COVID-19-related inhospital mortality in critical COVID-19 patients during intensive care unit admission: an observational cohort study.
34321249 2021. Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
34246503 2021. The link between nutritional status and outcomes in COVID-19 patients in ICU: Is obesity or sarcopenia the real problem?
34273661 2021. System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2.
34304682 2021. An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future.
34253126 2021. Enteroviruses and coronaviruses: similarities and therapeutic targets.
34236922 2021. Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy.
34232801 2021. Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.
34187281 2021. Tocilizumab for the treatment of non-critical COVID-19 pneumonia: an overview of the rationale and clinical evidence to date.
34294560 2021. Vitamin D supplementation for the treatment of COVID-19: Summary of a living Cochrane review.
34257036 2021. More Exercise linked to less severe Covid-19.
34284539 2021. Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19?
34311241 2022. Computational modeling predicts potential effects of the herbal infusion "horchata" against COVID-19.
34286803 2021. Immunonutrition effects on coping with COVID-19.
34209659 2021. Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CL(Pro)) Activity.
34249878 2021. Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study.
34222257 2021. Sphingolipids as Modulators of SARS-CoV-2 Infection.
34195193 2021. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.
34291081 2021. In silico Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19.
34277698 2021. Indian Ethnomedicinal Phytochemicals as Promising Inhibitors of RNA-Binding Domain of SARS-CoV-2 Nucleocapsid Phosphoprotein: An In Silico Study.
34235176 2021. Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2.
34220430 2021. COVID-19: Sleep, Circadian Rhythms and Immunity - Repurposing Drugs and Chronotherapeutics for SARS-CoV-2.
34322507 2021. Dairy-Derived and Egg White Proteins in Enhancing Immune System Against COVID-19.
34291074 2021. Nutritional Impact and Its Potential Consequences on COVID-19 Severity.
34222300 2021. Food Containing Bioactive Flavonoids and Other Phenolic or Sulfur Phytochemicals With Antiviral Effect: Can We Design a Promising Diet Against COVID-19?
34228597 2021. Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants.
34249614 2021. Central catecholaminergic blockade with clonidine prevent SARS-CoV-2 complication: A case series.
34314576 2021. SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.
34240083 2021. Targeting immunometabolism to treat COVID-19.
34312587 2021. In silico studies of Potency and safety assessment of selected trial drugs for the treatment of COVID-19.
34306960 2021. Computational assessment of select antiviral phytochemicals as potential SARS-Cov-2 main protease inhibitors: molecular dynamics guided ensemble docking and extended molecular dynamics.
34316174 2021. Gargling with 7.5% Sodium Bicarbonate Solution for SARS-CoV-2 Viremia Clearance: Our Institutional Clinical Experience.
34216123 2021. Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients.
34216119 2021. Effects of Interferon Beta in COVID-19 adult patients: Systematic Review.
34216117 2021. The Safety and Efficacy of Anakinra, an Interleukin-1 Antagonist in Severe Cases of COVID-19: A Systematic Review and Meta-Analysis.
34191910 2021. Music Therapy for the Treatment of Patients With COVID-19: Psychopathological Problems Intervention and Well-Being Improvement.
34276173 2021. Tocilizumab for Severe and Critical COVID-19 Pneumonia in Queens, NYC.
34276171 2021. Tocilizumab and SARS-CoV-2 (COVID-19): An Evolving Story, the Picture Is Clearer.
34198000 2021. Tocilizumab and COVID-19: Timing of administration assessment.
34251655 2021. COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review.
34247325 2021. Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia.
34244956 2021. Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis.
34319552 2021. Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial.
34302258 2021. Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series.
34296386 2021. Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations.
34285519 2021. Clinical Efficacy of Corticosteroids in the Early Stages of Deterioration in COVID-19 Pneumonia.
34244967 2021. Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany.
34247016 2021. Cyanorona-20: The first potent anti-SARS-CoV-2 agent.
34315117 2021. IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients.
34304002 2021. "Impact of pentaglobin in severe COVID 19 pneumonia- a prospective study."
34273635 2021. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial.
34224994 2021. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.
34217670 2021. Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.
34324908 2021. Chitosan derivatives: A suggestive evaluation for novel inhibitor discovery against wild type and variants of SARS-CoV-2 virus.
34263248 2021. In support of "Toxicity of herbal medications suggested as treatment for COVID-19: A narrative review".
34315010 2021. Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection.
34273098 2021. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study.
34289752 2021. Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332.
34225463 2021. 20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment.
34194277 2021. Outcome of early short-course corticosteroids in hospitalized patients with coronavirus disease-2019 (COVID-19): A report from a Saudi Arabian hospital.
34322403 2021. Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19.
34252497 2021. N-acetylcysteine for the treatment of COVID-19 among hospitalized patients.
34326009 2021. Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug.
34243049 2021. Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review.
34321903 2021. Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future.
34295173 2021. Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study.
34262324 2021. N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence.
34304092 2021. Melatonin interferes with COVID-19 at several distinct ROS-related steps.
34242027 2021. Peptidomimetic alpha-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability.
34328726 2021. Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein.
34313428 2021. 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents.
34213885 2021. Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.
34269012 2021. Pharmacokinetic interactions between the potential COVID-19 treatment drugs lopinavir/ritonavir and arbidol in rats.
34250317 2021. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19.
34222731 2021. Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients.
34303431 2021. Tocilizumab in COVID-19 therapy: who benefits, and how?
34303430 2021. Tocilizumab in COVID-19 therapy: who benefits, and how?
34245599 2021. Medical nutrition therapy for patients with malnutrition post-intensive care unit discharge: A case report of recovery from coronavirus disease 2019 (COVID-19).
34264798 2021. Reply: Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.
34264793 2021. Corticosteroids May Be Indicated in Children with Severe COVID-19 Disease.
34260481 2021. Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.
34260492 2021. Safety and Tolerability of Monoclonal Antibody Therapies for Treatment of COVID-19 in Pediatric Patients.
34256418 2021. Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis.
34315339 2021. Remdesivir analogs against SARS-CoV-2 RNA-dependent RNA polymerase.
34308790 2021. Design and in silico investigation of novel Maraviroc analogues as dual inhibition of CCR-5/SARS-CoV-2 M(pro).
34278965 2021. Identification of potential phytochemicals from Citrus Limon against main protease of SARS-CoV-2: molecular docking, molecular dynamic simulations and quantum computations.
34278954 2021. Computational studies on phylogeny and drug designing using molecular simulations for COVID-19.
34256681 2021. Dietary factors and SARS-CoV-2 contagion: in silico studies on modulation of viral and host proteins by spice actives.
34282078 2021. The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19.
34252978 2021. Possibility of PMX-DHP therapy as a principal strategy against cytokine storm in COVID-19: Insights from reconstructed coagulation data.
34191697 2021. Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19.
34254915 2021. Synthetic Attempts Towards Eminent Anti-Viral Candidates of SARS-CoV.
34250805 2021. Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation.
34285169 2021. Sinus Bradycardia in Children Treated With Remdesivir for COVID-19.
34218245 2021. The presence of anti-leucocyte antibodies in the plasma of convalescent women after SARS-CoV-2 infection as a reason for disqualification for plasma therapy - analysis based on a literature review.

34378108 2021. Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19.
34192090 2021. Multiscale Simulations of SARS-CoV-2 3CL Protease Inhibition with Aldehyde Derivatives. Role of Protein and Inhibitor Conformational Changes in the Reaction Mechanism.
34402717 2021. Resveratrol supplementation reduces ACE2 expression in human adipose tissue.
34379304 2021. Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey.
34374091 2021. Inhaled corticosteroids in early COVID-19-A tale of many facets.
34390598 2021. Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19.
34264890 2021. Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19, With Clinical Improvement in Most Patients.
34321405 2021. Effect of Subcutaneous Tocilizumab on Mortality in Patients With COVID-19: A Meta-analysis of Retrospective Cohort Studies.
34302183 2021. Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat.
34352377 2021. Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies.
34202941 2021. Evaluation of Microalgae Antiviral Activity and Their Bioactive Compounds.
34439061 2021. Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World.
34287229 2021. Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization.
34356384 2021. The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy.
34250275 2021. Peptide inhibitors against SARS-CoV-2 2'-O-methyltransferase involved in RNA capping: A computational approach.
34325131 2021. A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.
34303192 2021. Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
34271432 2021. Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro.
34198328 2021. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase.
34198327 2021. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease.
34198326 2021. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.
34198325 2021. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease.
34198324 2021. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.
34198323 2021. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
34198322 2021. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
34198321 2021. An all-out assault on SARS-CoV-2 replication.
34198320 2021. Author's overview: identifying SARS-CoV-2 antiviral compounds.
34248355 2021. In Silico Exploration of Phytoconstituents From Phyllanthus emblica and Aegle marmelos as Potential Therapeutics Against SARS-CoV-2 RdRp.
34211268 2021. A Computational-Based Drug Repurposing Method Targeting SARS-CoV-2 and its Neurological Manifestations Genes and Signaling Pathways.
34195940 2021. Decreased Serum Selenium Levels of COVID-19 Patients in Comparison with Healthy Individuals.
34206970 2021. Plant-Based Phytochemical Screening by Targeting Main Protease of SARS-CoV-2 to Design Effective Potent Inhibitors.
34237598 2021. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential.
34311539 2021. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
34311528 2021. Efficacy of Brazilian green propolis (EPP-AF(R)) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial.
34321172 2020. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.
34258282 2021. An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.
34258278 2021. Genome Features and In Vitro Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains.
34250095 2021. Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.
34204890 2021. Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein.
34201505 2021. The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity?
34207313 2021. Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer.
34201172 2021. Can Antiviral Activity of Licorice Help Fight COVID-19 Infection?
34206274 2021. Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type.
34246969 2021. Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 Receptor: In silico and in vitro studies.
34243074 2021. 3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2.
34214752 2021. New quinoline-triazole conjugates: Synthesis, and antiviral properties against SARS-CoV-2.
34329818 2021. Potent antiviral activity of Agrimonia pilosa, Galla rhois, and their components against SARS-CoV-2.
34271072 2021. A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors.
34214539 2021. Small molecule therapeutics to destabilize the ACE2-RBD complex: A molecular dynamics study.
34296811 2021. Maternal exposure to hydroxychloroquine and birth defects.
34261058 2021. Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series.
34215210 2021. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial.
34210259 2021. Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience.
34326122 2021. Preliminary results of clinical use of colchicine in COVID-19 treatment.
34226219 2021. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19.
34192157 2021. In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2.
34224585 2021. Yet another benefit from sunlight in the fight against COVID-19?
34295393 2021. Length of remdesivir treatment in patients with severe COVID-19.
34295392 2021. Does inhaled corticosteroid use affect the risk of COVID-19-related death?
34297817 2021. ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides.
34245241 2021. Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals.
34318597 2021. Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19.
34192469 2021. The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review.
34235720 2021. Baricitinib reduces 30-day mortality in older adults with moderate-to-severe COVID-19 pneumonia.
34275168 2021. Cytokine filter application in COVID-19 patients; island of hope for crash and burn patients or future solution for all septic acute respiratory distress syndrome (ARDS) patients.
34219277 2021. Hemoadsorption for management of patients on veno-venous ECMO support for severe COVID-19 acute respiratory distress syndrome.
34314507 2021. Efficacy of diammonium glycyrrhizinate combined with vitamin C for treating hospitalized COVID-19 patients: a retrospective, observational study.
34301378 2021. Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients.
34259775 2021. Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus.
34258894 2021. A case of COVID-19 infection quickly relieved after nasal instillations and gargles with povidone iodine.
34262773 2021. Intravenous immunoglobulin as adjuvant therapy for COVID-19: A case report and literature review.
34188630 2021. Comparison of Mc Grath-MAC and C-MAC video laryngoscopes for intubation in a COVID simulated mannequin by novice users wearing face protective gear: A randomized crossover trial.
34302004 2021. Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry.
34294743 2021. Long-term effects of malnutrition on severity of COVID-19.
34285313 2021. Solar UV-B/A radiation is highly effective in inactivating SARS-CoV-2.
34190409 2021. A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.
34278228 2021. Commentary: "Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19".
34453317 2021. Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.
34237151 2021. Protective role of cortistatin in pulmonary inflammation and fibrosis.
34235728 2021. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.
34213847 2021. COVID-19 and drugs: pathophysiology and therapeutic approaches.
34237949 2021. Triazavirin by mohol byť novovu nadejou v suboji s koronavirusom 2 vyvolavajucim ťažky akutny respiračny syndrom (SARS-CoV-2).
34278402 2021. SARS-CoV-2 M(pro) inhibition by a zinc ion: structural features and hints for drug design.
34252447 2021. Determination of camostat and its metabolites in human plasma - Preservation of samples and quantification by a validated UHPLC-MS/MS method.
34251312 2021. Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
34251307 2021. Efficacy and safety of tocilizumab in the management of COVID-19: a systematic review and meta-analysis of observational studies.
34301737 2021. Pharmacokinetics of Remdesivir and GS-441524 during PIRRT and Seraph 100 Therapy.
34258973 2021. Serum 25(OH)D Deficiency and High D-Dimer Levels are Associated with COVID-19 Pneumonia.
34323191 2021. A Meta-Analysis of Safety of Different Regimens of Remdesivir in COVID-19 Patients.
34315385 2021. Hydroxychloroquine and Azithromycin Combination in The Management of COVID-19 Infection: Safety and Effectiveness Challenges.
34315382 2021. COVID-19: Are Experimental Drugs Cure or Ill?
34313197 2021. Natural Products with tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 effects: A Drug Discovery Perspective against SARS-CoV-2.
34325642 2021. Fluvoxamine and amantadine: central nervous system acting drugs repositioned for COVID-19 as early intervention.
34250872 2021. Drug repurposing: an alternative strategy to treat COVID-19.
34225610 2021. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
34218774 2021. Withdrawal Notice: Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19
34225607 2021. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
34254927 2021. Visualized analyses of investigations upon mesenchymal stem/stromal cell-based cytotherapy and underlying mechanisms for COVID-19 associated ARDS.
34315369 2021. Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment.
34298488 2021. Hydroxychloroquine induces oxidative DNA damage and mutation in mammalian cells.
34268533 2021. Role of nitazoxanide as a repurposed drug in the treatment and management of various diseases.
34286500 2021. Fusobacterium nucleatum and alteration of the oral microbiome: from pregnancy to SARS-COV-2 infection.
34286486 2021. 2-Deoxy-D-glucose: is this the final cure for COVID-19: or yet another mirage?
34328807 2021. Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data.
34190669 2021. Low-dose aspirin for early COVID-19: does the early bird catch the worm?
34225541 2021. Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study.
34256643 2021. Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series.
34228996 2021. Janus kinase inhibitors in dermatology: Part II. A comprehensive review.
34189900 2021. The Case for Tocilizumab.
34189887 2021. Practice Pattern of Critical Care Physicians in India for Use of Corticosteroids in COVID-19.
34254564 2021. Emetine, a potent alkaloid for the treatment of SARS-CoV-2 targeting papain-like protease and non-structural proteins: pharmacokinetics, molecular docking and dynamic studies.
34253149 2021. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2.

34439542 2021. Therapeutic Potential of Alpha-Lipoic Acid in Viral Infections, including COVID-19.
34384825 2021. Polyphenylene carboxymethylene (PPCM) microbicide repurposed as antiviral against SARS-CoV-2. Proof of concept in primary human undifferentiated epithelial cells.
34302492 2021. Low-dose radiation therapy (LDRT) for COVID-19 and its deadlier variants.
34250455 2021. Intracerebral bleeding after janus-kinase inhibitor baricitinib for COVID-19.
34314511 2021. DrugWAS: Drug-wide Association Studies for COVID-19 Drug Repurposing.
34218393 2021. Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.
34221083 2021. Candidate Anti-COVID-19 Medicinal Plants from Ethiopia: A Review of Plants Traditionally Used to Treat Viral Diseases.
34306189 2021. Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial.
34195214 2021. Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial.
34305855 2021. Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors.
34327214 2021. Discovery of Small-Molecule Inhibitors of SARS-CoV-2 Proteins Using a Computational and Experimental Pipeline.
34322517 2021. Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19.
34305617 2021. Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations.
34305613 2021. Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19.
34305589 2021. Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening.
34305582 2021. Herbal Medicine, Gut Microbiota, and COVID-19.
34295250 2021. Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice.
34290613 2021. Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis.
34276386 2021. High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19.
34276356 2021. Remdesivir Inhibits Tubulointerstitial Fibrosis in Obstructed Kidneys.
34276355 2021. Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment.
34276351 2021. Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study.
34267664 2021. The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.
34267652 2021. Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.
34248620 2021. Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials.
34248612 2021. Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19.
34234668 2021. Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants.
34220524 2021. He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study.
34220507 2021. Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting M(pro) and Ameliorates Pulmonary Inflammation.
34220505 2021. Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences.
34220503 2021. Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.
34194331 2021. A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.
34290823 2021. Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study.
34290822 2021. Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective.
34306168 2021. Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation.
34306166 2021. In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database.
34277384 2021. Comparison of the Healing Effect of Nasal Saline Irrigation with Triamcinolone Acetonide Versus Nasal Saline Irrigation alone in COVID-19 Related Olfactory Dysfunction: A Randomized Controlled Study.
34216134 2021. Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19.
34237371 2021. Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2.
34239361 2021. Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19.
34328585 2021. Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data.
34306612 2021. Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients.
34209188 2021. Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19.
34209110 2021. Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment.
34208928 2021. Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M(pro) and Its Antiviral Activity in Cells against SARS-CoV-2.
34207220 2021. Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences.
34204256 2021. Antiviral Activity of Two Marine Carotenoids against SARS-CoV-2 Virus Entry In Silico and In Vitro.
34208755 2021. More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells.
34281262 2021. Conventional and Unconventional Approaches for Innovative Drug Treatments in COVID-19: Looking Outside of Plato's Cave.
34299333 2021. Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors.
34281181 2021. Antimicrobial Activity of Curcumin in Nanoformulations: A Comprehensive Review.
34281177 2021. Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.
34328586 2021. Quantum simulations of SARS-CoV-2 main protease M(pro) enable high-quality scoring of diverse ligands.
34287986 2021. Identification of novel inhibitors of SARS-CoV-2 main protease (M(pro) ) from Withania sp. by molecular docking and molecular dynamics simulation.
34293319 2021. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.
34195107 2021. Remdesivir - Current evidence & perspective in management of COVID-19 infection.
34326978 2021. Deep Learning Approach for Discovery of In Silico Drugs for Combating COVID-19.
34230687 2021. Synthesis of antimicrobial azoloazines and molecular docking for inhibiting COVID-19.
34244768 2021. Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model.
34279629 2021. Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019.
34273151 2021. Not All Monoclonal Antibodies for Coronavirus Disease 2019 Are Created Equal.
34271099 2021. Gut probiotic Lactobacillus rhamnosus attenuates PDE4B-mediated interleukin-6 induced by SARS-CoV-2 membrane glycoprotein.
34274845 2021. Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening.
34193209 2021. Regarding: "The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial".
34246301 2021. Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study.
34276042 2021. Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19.
34209485 2021. Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19.
34203564 2021. Electron Density Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase Complexes.
34202374 2021. Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.
34202092 2021. Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach.
34202844 2021. A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.
34206357 2021. Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma.
34205768 2021. Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study.
34205704 2021. Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization.
34199488 2021. Anti-Inflammatory, Antiallergic, and COVID-19 Main Protease (M(pro)) Inhibitory Activities of Butenolides from a Marine-Derived Fungus Aspergillus terreus.
34208050 2021. Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins.
34279439 2021. Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2.
34299505 2021. Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation.
34284567 2021. Pulmonary function, computerized tomography features and six-minute walk test at three months in severe COVID-19 patients treated with intravenous pulsed methylprednisolone: a preliminary report.
34284566 2021. Common anti-oxidant vitamin C as an anti-infective agent with remedial role on SARS-CoV-2 infection. An update.
34270114 2021. Clinical significance of prognostic nutrition index in hospitalized patients with COVID-19: Results from single-center experience with systematic review and meta-analysis.
34307731 2021. Reduced Mortality With Ondansetron Use in SARS-CoV-2-Infected Inpatients.
34229173 2021. Re-Du-Ning injection ameliorates LPS-induced lung injury through inhibiting neutrophil extracellular traps formation.
34220401 2021. State of the art in nonthermal plasma processing for biomedical applications: Can it help fight viral pandemics like COVID-19?
34189780 2021. Systematic review and meta-analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID-19): Evidence-base for practise and implications for research.
34227689 2021. The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.
34227110 2021. Upper age limits for convalescent plasma donation and treatment of COVID-19 patients: A further marker of ageism.
34216156 2021. Assessment of serological assays for identifying high titer convalescent plasma.
34269437 2021. Treating the endotheliopathy of SARS-CoV-2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products.
34224543 2021. Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients.
34387172 2021. Cardiovascular considerations of Remdesivir and Favipiravir in the treatment of COVID-19.
34337637 2021. Dinitrosyl iron complexes (DNICs) as inhibitors of the SARS-CoV-2 main protease.
34423563 2021. Drug Repurposing for the SARS-CoV-2 Papain-Like Protease.
34214339 2021. Phyllanthin and hypophyllanthin, the isolated compounds of Phyllanthus niruri inhibit protein receptor of corona virus (COVID-19) through in silico approach.
34218545 2021. A new application of mTOR inhibitor drugs as potential therapeutic agents for COVID-19.
34265888 2021. Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.
34229425 2021. Hypertonic saline with xylitol and hyaluronate may shorten the viral shedding duration in asymptomatic COVID-19 positive subjects: a pilot study.
34243689 2021. Prophylactic and therapeutic potential of selected immunomodulatory agents from Ayurveda against coronaviruses amidst the current formidable scenario: an in silico analysis.
34229582 2021. The molecular dynamics of possible inhibitors for SARS-CoV-2.
34225565 2021. Plant derived active compounds as potential anti SARS-CoV-2 agents: an in-silico study.
34328374 2021. In-silico study on viability of MXenes in suppressing the coronavirus infection and distribution.
34320905 2021. One microsecond MD simulations of the SARS-CoV-2 main protease and hydroxychloroquine complex reveal the intricate nature of binding.
34315340 2021. Combined molecular docking and dynamics simulations studies of natural compounds as potent inhibitors against SARS-CoV-2 main protease.
34308720 2021. Human Milk Antibodies Against SARS-CoV-2: A Longitudinal Follow-Up Study.
34297643 2021. SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination.
34295380 2021. Are statins beneficial for the treatment of SARS-CoV-2 infection?
34229805 2021. Interactions of Ozone-Functionalized Activated Charcoal with SARS-Cov-2 Proteases Using Molecular Docking and Dynamics.
34255596 2021. A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma.
34309463 2021. Could Immunonutrition Help in the Fight against COVID-19 in Cancer Patient?
34327928 2021. [Deficient micronutrient status of the population of various countries as a risk factor in COVID-19].
34245187 2021. A fast protein binding site comparison algorithm for proteome-wide protein function prediction and drug repurposing.
34293992 2021. The QSAR-search of effective agents towards coronaviruses applying the Monte Carlo method.

34230894 2021. Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display.
34257831 2021. Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.
34235330 2021. Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib.
34250348 2021. Anti-Covid-19 Drug Analogues: Synthesis of Novel Pyrimidine Thioglycosides as Antiviral Agents Against SARS-COV-2 and Avian Influenza H5N1 Viruses.
34309854 2021. Effects of inhaled nitric oxide in COVID-19-induced ARDS-Is it worthwhile?
34432408 2021. Probiotics in the times of COVID-19.
34251348 2021. Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.
34221871 2021. Can remdesivir and its parent nucleoside GS-441524 be potential oral drugs? An in vitro and in vivo DMPK assessment.
34249607 2021. Recent advances in developing small-molecule inhibitors against SARS-CoV-2.
34367893 2021. A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.
34294887 2021. Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates.
34267343 2021. Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation.
34349236 2021. Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein.
34351690 2021. How to increase cellular oxygen availability in COVID-19?
34366433 2021. La hidroxicloroquina como farmaco fundamental en dermatologia y su papel controvertido en la COVID-19.
34262779 2021. Current status of hyperbaric oxygen therapy for COVID-19.
34303107 2021. Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19.
34278613 2021. Secreted Expression of mRNA-Encoded Truncated ACE2 Variants for SARS-CoV-2 via Lipid-Like Nanoassemblies.
34196387 2021. Candidate immunomodulators for COVID-19: Heat-killed Mycobacterium w and BCG vaccine.
34341972 2021. The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis.
34351878 2021. Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis.
34294501 2021. Bamlanivimab infusion experience at one academic emergency department.
34223872 2021. Rapid implementation of pharmacy infusion services for emergency use authorization COVID-19 treatments at a field hospital.
34221942 2021. Impact of COVID-19 on Advanced Cancer Patients' Pain Care: Warning About Chloroquine and Hydroxychloroquine.
34278671 2021. Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation.
34230706 2021. Frontispiz: Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein.
34230708 2021. A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism.
34230707 2021. Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection.
34221397 2021. Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda.
34306677 2021. An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting.
34276987 2021. Clinical efficacy of Nafamostat Mesylate in combination with Favipiravir for COVID-19 pneumonia treatment review article.
34257103 2021. Titres and neutralising capacity of SARS-CoV-2-specific antibodies in human milk: a systematic review.
34229896 2021. Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial.
34278528 2021. The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.
34308145 2021. No evidence that vitamin D is able to prevent or affect the severity of COVID-19 in individuals with European ancestry: a Mendelian randomisation study of open data, by Amin et al.
34308142 2021. Critical care nutrition and COVID-19: a cause of malnutrition not to be underestimated.
34308134 2021. Plant-based diets, pescatarian diets and COVID-19 severity: a population-based case-control study in six countries.
34308129 2021. Genetically predicted serum vitamin D and COVID-19: a Mendelian randomisation study.
34308122 2021. Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app.
34261689 2021. Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors.
34207861 2021. Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?
34308537 2021. A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19.
34227929 2021. COVID-19 in children: acute endotheliopathy, but forgotten prostacyclin replacement?
34246277 2021. Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching.
34255300 2021. Plausible Positive Effects of Statins in COVID-19 Patient.
34320401 2021. Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication.
34234570 2021. Virucidal Activity of the Antiseptic Mouthwash and Dental Gel Containing Anionic Phthalocyanine Derivative: In vitro Study.
34326460 2021. Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection.
34271420 2021. Efficient machine learning model for predicting drug-target interactions with case study for Covid-19.
34329860 2021. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study.
34311261 2021. Identifying potential human and medicinal plant microRNAs against SARS-CoV-2 3'UTR region: A computational genomics assessment.
34273770 2021. Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors.
34256255 2021. Drug repurposing against SARS-CoV-2 receptor binding domain using ensemble-based virtual screening and molecular dynamics simulations.
34252682 2021. Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape.
34247134 2021. HANA: A Healthy Artificial Nutrition Analysis model during COVID-19 pandemic.
34242870 2021. In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic simulation study.
34216889 2021. In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.
34306873 2021. Diffuse Alveolar Hemorrhage With Avelumab Maintenance Therapy.
34274470 2021. Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19.
34250314 2021. Relevance of vitamin D3 in COVID-19 infection.
34218488 2021. A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID-19.
34209870 2021. Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19.
34199214 2021. Impact of Prophylactic Hydroxychloroquine on People at High Risk of COVID-19: A Systematic Review and Meta-Analysis.
34300178 2021. In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2.
34313585 2021. Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19.
34292870 2021. Inhalable nanocatchers for SARS-CoV-2 inhibition.
34271164 2021. Fibrinolytic or anti-plasmin (nafamostat) therapy for COVID-19: A timing challenge for clinicians.
34192261 2020. A New Natural Defense Against Airborne Pathogens.
34305198 2021. Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication.
34245622 2021. Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis.
34297311 2021. TNF-alpha Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study.
34316436 2021. TNF-alpha Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study.
34226782 2021. Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.
34305428 2021. Previously published ethno-pharmacological reports reveal the potentiality of plants and plant-derived products used as traditional home remedies by Bangladeshi COVID-19 patients to combat SARS-CoV-2.
34305423 2021. Use of allopathic and complementary medicine for preventing SARS-CoV-2 infection in Mexican adults: A national survey.
34274797 2021. The role of antipsychotics against COVID-19: A topic for debate.
34217549 2021. Letter on: "Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population".
34215466 2021. An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.
34193418 2021. Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.
34308004 2021. Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study.
34236264 2021. Efficacy of tocilizumab in COVID-19: A review of the current evidence.
34239034 2021. Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients.
34234253 2021. Informing selection of drugs for COVID-19 treatment through adverse events analysis.
34272426 2021. In vitro efficacy of artemisinin-based treatments against SARS-CoV-2.
34253743 2021. Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro.
34326308 2021. Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation.
34262013 2021. Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.
34192119 2021. Can Tofacitinib Offer Protection against COVID-19 Infection?
34192965 2021. Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.
34268440 2021. Platelet lysate for COVID-19 pneumonia-a newer adjunctive therapeutic avenue.
34315546 2021. Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
34271988 2021. Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial.
34266486 2021. Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction.
34319510 2021. Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey.
34211556 2021. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update.
34230996 2021. Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).
34234442 2021. Therapeutic Agents Rounding Up the Immunopathology of COVID-19.
34238584 2021. Harnessing immunotherapy to combat COVID-19: A modern snake oil or silver bullet?
34293538 2021. Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19.
34231858 2021. Clozapinebehandeling en COVID-19: doorgaan ondanks leukocytopenie en spiegelstijging.
34285885 2021. Repurposing colchicine's journey in view of drug-to-drug interactions. A review.
34306523 2021. A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients.
34247970 2021. Sequential dosing of convalescent COVID-19 plasma with significant temporal clinical improvements in a persistently SARS-COV-2 positive patient.
34308605 2021. Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study.
34307564 2021. Controversies' clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages.
34307545 2021. Enhancing oxygenation of patients with coronavirus disease 2019: Effects on immunity and other health-related conditions.
34197067 2021. Comment on "Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak".
34260218 2021. Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative.
34192471 2021. Low radiation dose to treat pneumonia and other inflammations.
34227789 2021. Favipiravir Induced Nephrotoxicity in Two Patients of COVID-19.
34227770 2021. Role of Mycobacterium w for the Treatment of COVID-19: An Observational Study.
34274727 2021. Molecular insight on the formation structure and dynamics of melatonin in an aqueous solution and at the Water-Air interface: A molecular dynamics study.

34415722 2021. OFF-State-Specific Inhibition of the Proprotein Convertase Furin.
34387564 2021. Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19.
34375047 2021. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19.
34377451 2021. Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India.
34367631 2021. Budesonide: A promising candidate therapeutic for early COVID-19.
34386694 2021. SARS-CoV-2 receptor-binding mutations and antibody contact sites.
34396040 2021. Application of an integrated computational antibody engineering platform to design SARS-CoV-2 neutralizers.
34356745 2021. Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling.
34438980 2021. Treating Critically Ill Patients Experiencing SARS-CoV-2 Severe Infection with Ig-M and Ig-A Enriched Ig-G Infusion.
34356777 2021. Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19.
34375715 2021. A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency.
34423407 2021. Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections.
34456656 2021. SANE: A sequence combined attentive network embedding model for COVID-19 drug repositioning.
34331101 2021. The sufficient vitamin D and albumin level have a protective effect on COVID-19 infection.
34337739 2021. Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia.
34420546 2021. The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a case-control study of COVID-19 patients.
34410360 2021. Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.
34313439 2021. Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns.
34313421 2021. Determination of Ligand Binding Modes in Hydrated Viral Ion Channels to Foster Drug Design and Repositioning.
34297570 2021. Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19.
34279924 2021. Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 M(pro).
34232288 2021. Role of vitamin D in COVID-19: active or passive?
34196415 2021. Corticosteroids in COVID-19: We Should Be Mindful of Their Acute Toxicities.
34221930 2021. Current and New Drugs for COVID-19 Treatment and Its Effects on the Liver.
34211649 2021. Potential predictors of outcomes among hospitalized COVID-19 patients treated with convalescent plasma: a single-center study.
34272647 2021. Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis.
34255214 2021. Andrographolide binds to spike glycoprotein and RNA-dependent RNA polymerase (NSP12) of SARS-CoV-2 by in silico approach: a probable molecule in the development of anti-coronaviral drug.
34326998 2021. Arbidol is associated with increased in-hospital mortality among 109 patients with severe COVID-19: A multicenter, retrospective study.
34247526 2021. The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients.
34313036 2021. A Case Report for Severe COVID-19 in a 9-Year-Old Child Treated with Remdesivir and Dexamethasone.
34203880 2021. Dexamethasone in the Treatment of COVID-19: Primus Inter Pares?
34265236 2021. Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India.
34294374 2021. Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2.
34228472 2021. Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody.
34297554 2021. Structural Decoding of a Small Molecular Inhibitor on the Binding of SARS-CoV-2 to the ACE 2 Receptor.
34319118 2021. Accelerating COVID-19 Research Using Molecular Dynamics Simulation.
34264329 2021. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
34264868 2021. Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide.
34192120 2021. Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases.
34302746 2021. Dapagliflozin in patients with COVID-19: truth or dare.
34302745 2021. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.
34242581 2021. Cytokine adsorption and ECMO in patients with COVID-19.
34242580 2021. Cytokine adsorption and ECMO in patients with COVID-19 - Author's reply.
34242579 2021. Cytokine adsorption and ECMO in patients with COVID-19.
34207199 2021. Photobiomodulation Therapy as a Possible New Approach in COVID-19: A Systematic Review.
34208435 2021. Statins in COVID-19 Therapy.
34321327 2021. High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
34259182 2021. Placing the results of the SOLIDARITY trial with regards to remdesivir in perspective.
34313527 2021. Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV.
34260531 2021. Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.
34312610 2021. Saffron for "toning down" COVID-19-related cytokine storm: Hype or hope? A mini-review of current evidence.
34250458 2021. Vitamin D in infectious complications in critically ill patients with or without COVID-19.
34311016 2021. Interferon beta, an enhancer of the innate immune response against SARS-CoV-2 infection.
34269015 2021. Clinical course and serial chest ultra-low-dose CT findings in a patient with COVID-19 treated with remdesivir.
34257311 2021. Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
34210968 2021. The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells.
34191921 2020. COVID-19 Pandemic: A Case for Phytomedicines.
34305226 2021. Remdesivir en pacientes trasplantados renales con neumonia por SARS-CoV-2.
34193864 2021. Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19.
34232998 2021. Diverse high-affinity DNA aptamers for wild-type and B.1.1.7 SARS-CoV-2 spike proteins from a pre-structured DNA library.
34232992 2021. SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction.
34206219 2021. Vitamin D Metabolites and Clinical Outcome in Hospitalized COVID-19 Patients.
34203027 2021. Dietary Behaviors and Incident COVID-19 in the UK Biobank.
34203015 2021. Clinical Significance of Micronutrient Supplementation in Critically Ill COVID-19 Patients with Severe ARDS.
34294503 2021. Increased risk for Covid-19 in patients with Vitamin D deficiency.
34327256 2021. Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19.
34192270 2021. The role and uses of antibodies in COVID-19 infections: a living review.
34203977 2021. Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2.
34203643 2021. Rapid Inactivation of SARS-CoV-2 Variants by Continuous and Intermittent Irradiation with a Deep-Ultraviolet Light-Emitting Diode (DUV-LED) Device.
34208061 2021. Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2.
34278363 2021. Integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action.
34286302 2021. Generating hard-to-obtain information from easy-to-obtain information: Applications in drug discovery and clinical inference.
34187503 2021. Intravenous administration of anakinra in children with macrophage activation syndrome.
34322316 2021. The impact of curcumin derived polyphenols on the structure and flexibility COVID-19 main protease binding pocket: a molecular dynamics simulation study.
34200456 2021. Therapeutic Potential of Glycosyl Flavonoids as Anti-Coronaviral Agents.
34198933 2021. Scaffold Hopping of alpha-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 M(Pro) Inhibitor.
34203242 2021. Aptamer Applications in Emerging Viral Diseases.
34202350 2021. Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System.
34201587 2021. Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library.
34200425 2021. Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects.
34202584 2021. Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles.
34302047 2021. G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.
34314863 2021. Ultraviolet-A light reduces cellular cytokine release from human endotracheal cells infected with Coronavirus.
34324563 2021. Topological network based drug repurposing for coronavirus 2019.
34320004 2021. Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19.
34314458 2021. Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women.
34310603 2021. Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assay.
34297766 2021. Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings.
34242340 2021. Efficacy of "Essential Iodine Drops" against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
34214123 2021. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study.
34197523 2021. A public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong.
34265018 2021. Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.
34252168 2021. Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.
34228761 2021. Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques.
34193549 2021. Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts.
34219928 2021. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness.
34234012 2021. Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.
34210738 2021. Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection.
34403258 2021. Targeting Ribosomal Frameshifting as an Antiviral Strategy: From HIV-1 to SARS-CoV-2.
34370690 2021. Laboratory parameters predicting mortality of adult in-patients with COVID-19 associated cytokine release syndrome treated with high-dose tocilizumab.
34383442 2021. Inhaled Budesonide Reduces the Risk of Emergency Department Evaluation or Hospitalization in Early COVID-19.
34358400 2021. Diffuse C4d staining of peritubular capillaries in renal allograft following bamlanivimab therapy.
34403399 2021. Is Aspirin the True Protective Therapy in Coronavirus Disease 2019 Patients?
34428080 2021. SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment.
34427335 2021. Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: Bioinformatic studies.
34339400 2021. Impact of CytoSorb Hemoadsorption on Sedation Requirements in Patients With Severe COVID-19 on Venovenous Extracorporeal Membrane Oxygenation.
34375133 2021. Repurposing Psychotropic Agents for Viral Disorders: Beyond Covid.
34397376 2021. Obesite, inflammation et COVID-19 : interet preventif de l'alimentation cetogene ?
34417268 2021. Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges.
34458995 2021. Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response.
34423353 2021. Recent omics-based computational methods for COVID-19 drug discovery and repurposing.
34253645 2021. Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters.

34217752 2021. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.
34212286 2021. Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M(pro): Bioinformatics Approach.
34324152 2021. Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach.
34287520 2021. Short-term changes in ganglion cell complex in patients with COVID-19 treated with hydroxychloroquine.
34191420 2021. Early enteral nutrition improves the outcome of critically ill patients with COVID-19: A retrospective study.
34243953 2021. Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis.
34272755 2021. Traditional medicines for COVID-19: Perspectives from clinical pharmacologists.
34327732 2021. Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trial.
34318516 2021. COVID-19 acute respiratory distress syndrome: A simulation study of the effects of combination therapy with tocilizumab and siltuximab.
34305155 2021. In silico investigation to identify potential small molecule inhibitors of the RNA-dependent RNA polymerase (RdRp) nidovirus RdRp-associated nucleotidyltransferase domain.
34212944 2021. A critical overview of computational approaches employed for COVID-19 drug discovery.
34230893 2021. Novel 1,2,3-Triazole Derivatives as Potential Inhibitors against Covid-19 Main Protease: Synthesis, Characterization, Molecular Docking and DFT Studies.
34242492 2021. MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L.
34312571 2021. Identification of Food Compounds as inhibitors of SARS-CoV-2 main protease using molecular docking and molecular dynamics simulations.
34208141 2021. The Role of Therapeutic Plasma Exchange (TPE) in Multisystem Inflammatory Syndrome in Children (MIS-C).
34279822 2021. Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19?
34189958 2021. Acetylsalicylic Acid and COVID-19 Prevention: A Comment.
34322890 2021. Remdesivir therapy associated with Bradycardia in SARS-CoV2.
34190859 2021. CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk.
34226272 2021. Le tocilizumab pour les patients hospitalises atteints de la COVID-19.
34318930 2021. Ivermectin for preventing and treating COVID-19.
34212566 2021. Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report.
34192247 2020. Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.
34194882 2021. Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.
34188995 2021. Functional and Radiological Improvement in a COVID-19 Pneumonia Patient Treated With Steroids.
34249604 2021. COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks.
34271264 2021. Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19.
34256351 2021. Time to 'Mind the Gap' in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2.
34218010 2021. Progress and pitfalls of a year of drug repurposing screens against COVID-19.
34306988 2021. Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach.
34247039 2021. Clinical applications of thrombopoietin silencing: A possible therapeutic role in COVID-19?
34237556 2021. Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study.
34203409 2021. The Potential Use of Vitamin C to Prevent Kidney Injury in Patients with COVID-19.
34222847 2021. Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial.
34225477 2021. Implication of epitranscriptomics in trained innate immunity and COVID-19.
34221256 2021. A prolonged steroid therapy may be beneficial in some patients after the COVID-19 pneumonia.
34222786 2021. Complete heart block associated with Remdesivir in COVID-19: a case report.
34245744 2021. Effects of antiviral drug therapy on dynamic thiol/disulphide homeostasis and nitric oxide levels in COVID-19 patients.
34307281 2021. Traditional Chinese Medicine Enema Therapy in a Patient With a Confirmed Negative SARS-CoV-2 Test in the Respiratory Tract but Positive in the Intestinal Tract: A Case Report.
34307269 2021. Efficacy of Integrated Traditional Chinese and Western Medicine for Treating COVID-19: A Systematic Review and Meta-Analysis of RCTs.
34273049 2021. Therapeutic prevention of COVID-19 in elderly: a case-control study.
34285902 2021. Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre.
34195036 2021. Nutritional approach for increas-ing public health during pandemic of COVID-19: A comprehensive review of antiviral nutrients and nutraceuticals.
34189331 2021. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.
34312598 2021. Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19.
34239286 2020. Potential SARS-COV preclinical (in vivo) compounds targeting COVID-19 main protease: a meta-analysis and molecular docking studies.
34272571 2021. Stellungnahme zum Einsatz von topisch-inhalativem Budesonid bei COVID-19-Infektion : Positionspapier des Arzteverbands Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft fur Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie (DGHNO-KHC).
34230874 2021. In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CL(pro)) and SARS-CoV-2 (M(pro)).
34224069 2021. Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly.
34189252 2021. In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (M(pro)) and spike (S) receptor.
34322971 2021. The role of vitamin D in the age of COVID-19: A systematic review and meta-analysis.
34310814 2021. Insufficient evidence for vitamin D use in COVID-19: A rapid systematic review.
34202694 2021. Vitamin D, SARS-CoV-2 and Causal Associations in Transversal Studies: The Time-Series Analysis to Reveal Potential Confounders. Comment on Gaudio et al. Vitamin D Levels Are Reduced at the Time of Hospital Admission in Sicilian SARS-CoV-2-Positive Patients. Int. J. Environ. Res. Public Health 2021, 18, 3491.
34198578 2021. Dietary Intake and Supplement Use Among Saudi Residents during COVID-19 Lockdown.
34299717 2021. Association of Food Intake Quality with Vitamin D in SARS-CoV-2 Positive Patients from Mexico: A Cross-Sectional Study.
34281096 2021. A Possible Preventive Role of Physically Active Lifestyle during the SARS-CoV-2 Pandemic; Might Regular Cold-Water Swimming and Exercise Reduce the Symptom Severity of COVID-19?
34299925 2021. The Positive Role of Tai Chi in Responding to the COVID-19 Pandemic.
34280973 2021. Reply to Ialongo et al. Vitamin D, SARS-CoV-2 and Causal Associations in Transversal Studies: The Time-Series Analysis to Reveal Potential Confounders. Comment on "Gaudio et al. Vitamin D Levels Are Reduced at the Time of Hospital Admission in Sicilian SARS-CoV-2-Positive Patients. Int. J. Environ. Res. Public Health 2021, 18, 3491".
34194240 2021. Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial.
34285682 2021. Inclination toward herbal remedies as immunity boosters and anti-stress agents during COVID-19 pandemic: A short report.
34249284 2021. Pulmonary Covid Fibrosis a New Pharmaceutic Approach.
34249275 2021. Prevention of SARS-CoV-2 Infection: A Liposomal Functional Food Approach.
34251506 2021. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial.
34223922 2021. Do not just sit there, do something ... but do no harm: the worrying aspects of COVID-19 experimental interventions.
34324157 2021. In Silico Mutagenesis-Based Remodelling of SARS-CoV-1 Peptide (ATLQAIAS) to Inhibit SARS-CoV-2: Structural-Dynamics and Free Energy Calculations.
34308530 2021. Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2.
34275096 2021. High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study.
34191054 2021. Inhalatives Budesonid zur Therapie bei COVID-19.
34268226 2020. Vitamin D3 Administration to Patients with Confirmed COVID-19.
34226835 2021. A prospective study on COVID-19 convalescent plasma donor (CCP) recruitment strategies in a resource constrained blood centre.
34316549 2021. Effect of time and titer in convalescent plasma therapy for COVID-19.
34278249 2021. The strand-biased transcription of SARS-CoV-2 and unbalanced inhibition by remdesivir.
34273580 2021. Reply to "Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era".
34273579 2021. Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era.
34246440 2021. The impact of inhaled corticosteroid on SARS-CoV2 infection.
34287171 2021. Observations of Polypharmacy and Interactions on Varying COVID-19 Medication Regimens in Nursing Home Residents.
34264384 2021. Tocilizumab in patients with COVID-19: which patient, time, and dose?
34226805 2021. Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.
34188417 2021. Clinical outcomes among COVID-19 patients managed with modern and traditional Siddha medicine -A retrospective cohort study, Chennai, Tamil Nadu, India, 2020.
34276163 2021. "Standalone Ayurvedic treatment of high-risk COVID-19 patients with multiple comorbidities: A case series."
34230788 2021. Application Of A Non-Linear Multi-Model Ayurveda Intervention In Elderly COVID-19 Patients- A Retrospective Case Series.
34305355 2021. Role of Ayurveda and Yoga-Based lifestyle in the COVID-19 Pandemic - A Narrative Review.
34276164 2021. Ayurvedic evaluation and treatment of Covid 19: A Case Report.
34214498 2021. Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection.
34254034 2021. Clinical efficacy of low-dose emetine for patients with COVID-19: a real-world study.
34270179 2021. Clinical Features and Outcome of Low and High Corticosteroids in Admitted COVID-19 Patients.
34319869 2021. Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir.
34287040 2021. Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.
34309975 2021. Mouthwashes in COVID-19: Benefit or harm to the oral microbiome?
34245078 2021. Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.
34328670 2021. Bamlanivimab use in mild-to-moderate COVID-19 disease: A matched cohort design.
34283020 2021. What if melatonin could help COVID-19 severe patients?
34282982 2021. Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.
34232002 2021. Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2.
34231415 2021. Impact of Tocilizumab on Clinical Outcomes in COVID-19-Associated Cytokine Release Syndrome: A Single-Center Experience.
34283183 2021. Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial.
34319350 2021. Uberantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines.
34269813 2021. Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial.
34228779 2021. IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?
34228774 2021. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
34239661 2021. Acupuncture for Treating Hypertension and Type 2 Diabetes Mellitus as Comorbidities in Patients with COVID-19.
34193999 2021. Engineered single-domain antibodies tackle COVID variants.
34191617 2021. Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target?
34264764 2021. Ultraviolet C Supported Novel Phototherapy Units at the Crossroads of the COVID-19 Pandemic.
34223589 2021. Corilagin and 1,3,6-Tri-O-galloy-beta-D-glucose: potential inhibitors of SARS-CoV-2 variants.
34293161 2021. Low vitamin D levels and prognosis in a COVID-19 pediatric population: a systematic review.
34257144 2021. A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.
34326236 2021. Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.
34285133 2021. Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.
34210892 2021. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.
34296692 2021. [Meta analysis on the treatment of coronavirus disease 2019 by traditional Chinese and Western medicine].

34279840 2021. Curcumin and Piperine in COVID-19: A Promising Duo to the Rescue?
34279839 2021. Cinnamon: A Promising Natural Product Against COVID-19.
34279838 2021. Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).
34279837 2021. COVID-19, Coenzyme Q10 and Selenium.
34279836 2021. Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review.
34225580 2021. Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.
34216205 2021. Consequences of rush to emergency use authorization of bamlanivimab.
34196543 2021. Protein Engineering in the Design of Protein-Protein Interactions: SARS-CoV-2 Inhibitors as a Test Case.
34227154 2021. Accelerated stability study of the ester prodrug remdesivir: Recently FDA-approved Covid-19 antiviral using reversed-phase-HPLC with fluorimetric and diode array detection.
34301158 2021. Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets.
34196258 2021. Ibuprofen and COVID-19 disease: separating the myths from facts.
34370620 2021. Association of 25-Hydroxyvitamin D Level with COVID-19-Related in-Hospital Mortality: A Retrospective Cohort Study.
34450619 2021. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.
34431263 2021. Clinical Study of Use of Remdesivir and Tocilizumab in Severely Ill COVID-19 Patients.
34431262 2021. Post COVID-19 Mucormycosis in the Second Wave-Realities, Uncertainties and Myths.
34380185 2021. Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility.
34370631 2021. Quantitative structure-activity relationships, molecular docking and molecular dynamics simulations reveal drug repurposing candidates as potent SARS-CoV-2 main protease inhibitors.
34370622 2021. Polypharmacology of some medicinal plant metabolites against SARS-CoV-2 and host targets: Molecular dynamics evaluation of NSP9 RNA binding protein.
34348081 2021. Flavan-based phytoconstituents inhibit Mpro, a SARS-COV-2 molecular target, in silico.
34459720 2021. Ebselen suitably interacts with the potential SARS-CoV-2 targets: an in-silico approach.
34455933 2021. Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase.
34455932 2021. In silico screening of FDA approved drugs against ACE2 receptor: potential therapeutics to inhibit the entry of SARS-CoV-2 to human cells.
34448684 2021. MD simulation and MM/PBSA identifies phytochemicals as bifunctional inhibitors of SARS-CoV-2.
34431452 2021. Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: in silico molecular docking and dynamic simulation studies.
34431451 2021. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from Aegle marmelos deciphered using molecular docking analysis.
34427179 2021. In silico study on spice-derived antiviral phytochemicals against SARS-CoV-2 TMPRSS2 target.
34424815 2021. In silico screening of Pueraria tuberosa (PTY-2) for targeting COVID-19 by countering dual targets M(pro) and TMPRSS2.
34424151 2021. Venetoclax: a promising repurposed drug against SARS-CoV-2 main protease.
34415218 2021. Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study.
34338602 2021. In silico analysis of marine natural product from sponge (Clathria Sp.) for their activity as inhibitor of SARS-CoV-2 Main Protease.
34405765 2021. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19.
34396938 2021. Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2.
34379031 2021. Designing Self-Inhibitory fusion peptide analogous to viral spike protein against novel severe acute respiratory syndrome (SARS-CoV-2).
34341313 2021. QTc prolongation and mortality in SARS-2-CoV-infected patients treated with azithromycin and hydroxychloroquine.
34403259 2021. Discovery of Novel Small-Molecule Inhibitors of SARS-CoV-2 Main Protease as Potential Leads for COVID-19 Treatment.
34387990 2021. Machine Learning Models Identify Inhibitors of SARS-CoV-2.
34383045 2021. Letter to the Editor from Viola Viola: "Calcifediol treatment and COVID-19-related outcomes".
34431552 2021. Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis.
34416093 2021. Frequency of COVID-19 in acne patients treated with oral doxycycline: A retrospective cross-sectional comparative study.
34405764 2021. A Combination of alpha-Lipoic Acid (ALA) and Palmitoylethanolamide (PEA) Blocks Endotoxin-Induced Oxidative Stress and Cytokine Storm: A Possible Intervention for COVID-19.
34397203 2021. COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients.
34353257 2021. Nature-derived hit, lead, and drug-like small molecules: Current status and future aspects against key target proteins of Coronaviruses.
34353251 2021. The Promising Enzymes for Inhibitors Development against COVID-19.
34407336 2021. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
34407335 2021. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
34407334 2021. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
34375967 2021. A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2.
34417590 2021. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
34400835 2021. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
34363064 2021. Coronapod: Ivermectin, what the science says.
34341573 2021. Flawed ivermectin preprint highlights challenges of COVID drug studies.
34369338 2021. Vitamin D and acute and severe illness - a mechanistic and pharmacokinetic perspective.

34458381 2021. Interaction of SARS-CoV-2 spike protein with angiotensin converting enzyme inhibitors and selected compounds from the chemical entities of biological interest.
34371003 2021. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
34343644 2021. Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view.
34389380 2021. EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus.
34336604 2021. Would the interference phenomenon be applied as an alternative option for prophylaxis against COVID-19?
34393433 2021. Molecular docking analysis of SARS-CoV-2 linked RNA dependent RNA polymerase (RdRp) with compounds from Plectranthus amboinicus.
34393413 2021. Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2.
34433426 2021. Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System.
34448983 2021. Exploring the Role of Heavy Metals and Their Derivatives on the Pathophysiology of COVID-19.
34440024 2021. Phytochemicals from Leucas zeylanica Targeting Main Protease of SARS-CoV-2: Chemical Profiles, Molecular Docking, and Molecular Dynamics Simulations.
34399199 2021. Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations.
34388532 2021. COVID-19 challenges and its therapeutics.
34388530 2021. GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
34358753 2021. In silico drug repurposing in COVID-19: A network-based analysis.
34339917 2021. Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection.
34332377 2021. A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status.
34337036 2021. Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19.
34440222 2021. Vivo-Morpholino-Based Antiviral for SARS-CoV-2: Implications for Novel Therapies in the Treatment of Acute COVID-19 Disease.
34440200 2021. SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System.
34398357 2021. Antiviral properties of copper and its alloys to inactivate covid-19 virus: a review.
34439781 2021. Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2.
34439920 2021. Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives.
34333425 2021. Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage.
34450570 2021. Potency and pharmacokinetics of GS-441524 derivatives against SARS-CoV-2.
34438338 2021. Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic.
34332853 2021. Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors.
34418570 2021. Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors.
34428682 2021. Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach.
34396086 2021. SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review.
34379353 2021. Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies.
34407530 2021. Hemoperfusion with CytoSorb(R) in Critically Ill COVID-19 Patients.
34369870 2021. Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light.
34334126 2021. A phenomics approach for antiviral drug discovery.
34384388 2021. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.
34344651 2021. Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab.
34433539 2021. High-titre convalescent plasma therapy for an immunocompromised patient with systemic lupus erythematosus with protracted SARS-CoV-2 infection.
34344672 2021. New prophylaxis regimen for SARS-CoV-2 infection in health professionals with low doses of hydroxychloroquine and bromhexine: a randomised, double-blind placebo clinical trial (ELEVATE Trial).
34376401 2021. Efficacy of convalescent plasma for treatment of COVID-19 in Uganda.
34399981 2021. Vasopressin infusion in COVID-19 critical illness is not associated with impaired viral clearance: a pilot study.
34390646 2021. Self-prescribed Ivermectin use is associated with a lower rate of seroconversion in health care workers diagnosed with COVID, in a dose-dependent response.
34368837 2021. A novel framework integrating AI model and enzymological experiments promotes identification of SARS-CoV-2 3CL protease inhibitors and activity-based probe.
34406213 2021. O negacionismo enquanto politica: o debate da cloroquina em uma comissao parlamentar.
34416148 2021. Tackling COVID-19 with neutralizing monoclonal antibodies.
34404919 2021. Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection.
34385423 2021. Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo.
34349098 2020. Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients.
34420051 2021. Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone.
34410348 2021. Pre-Hospital Administration of Remdesivir during a SARS-CoV-2 Outbreak in a Skilled Nursing Facility.
34409989 2021. Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization.
34366437 2021. Molecular dynamics simulations of quinine encapsulation into biodegradable nanoparticles: A possible new strategy against Sars-CoV-2.
34446469 2021. Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
34335827 2021. Hydrogen Peroxide as an Adjuvant Therapy for COVID-19: A Case Series of Patients and Caregivers in the Mexico City Metropolitan Area.
34412564 2021. An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19).
34424130 2021. The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism.
34348067 2021. Anti-inflammatory effects of GLP-1 in patients with COVID-19.
34458164 2021. Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach.
34395311 2021. Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection.
34456929 2021. Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy.
34456928 2021. DAMPening COVID-19 Severity by Attenuating Danger Signals.
34421902 2021. BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity.
34408751 2021. Case Report: C-Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase.
34408744 2021. Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study.
34394132 2021. Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells.
34381462 2021. Immediate Pre-Partum SARS-CoV-2 Status and Immune Profiling of Breastmilk: A Case-Control Study.
34381460 2021. Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies.
34367135 2021. CAR Macrophages for SARS-CoV-2 Immunotherapy.
34367128 2021. CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro.
34414206 2021. Poliovirus Vaccination Induces a Humoral Immune Response That Cross Reacts With SARS-CoV-2.
34350193 2021. Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial.
34268806 2021. In vitro inhibition and molecular docking of a new ciprofloxacin-chalcone against SARS-CoV-2 main protease.
34424332 2021. Potential Value of Electroacupuncture in the Treatment of Gastrointestinal Symptoms of COVID-19.
34427297 2021. A review of remdesivir for COVID-19 in pregnancy and lactation.
34409431 2021. Remdesivir and Mortality in Patients with COVID-19.
34455583 2021. First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19.
34350582 2021. Remdesivir for the treatment of COVID-19.
34396514 2021. Systemic corticosteroids for the treatment of COVID-19.
34384300 2021. Addendum to vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis.
34384298 2021. Letter to editor "vitamin D deficiency aggravates covid-19: systematic review and meta-analysis".
34384289 2021. Vitamin D deficiency aggravates COVID-19: discussion of the evidence.
34382897 2021. Zinc nutrition and dietary zinc supplements.
34348019 2021. COVID-19 Infection: Targeting Possibilities for Treatment.
34353261 2021. siRNA as a potential therapy for COVID-19.
34365935 2021. Clinical Efficacy of Remdesivir and Favipiravir in the Treatment of Covid-19 Patients: Scenario So Far.
34370633 2021. Molecular Modeling Targeting Transmembrane Serine Protease 2 (TMPRSS2) as an Alternative Drug Target Against Coronaviruses.
34420502 2021. Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp).
34382513 2021. Comprehensive analysis of SARS-COV-2 drug targets and pharmacological aspects in treating the COVID-19.
34375189 2021. The use of pseudotyped coronaviruses for the screening of entry inhibitors: Green tea extract inhibits the entry of SARS-CoV-1, MERS-CoV, and SARS-CoV-2 by blocking receptor-spike interaction.
34459375 2021. The Use of Lectins as Tools to Combat SARS-CoV-2.
34455948 2021. A systematic review and meta-analysis of the safety of Hydroxychloroquine in a randomized controlled trial and observational studies.
34357885 2021. Exercise Is Medicine for Immune Function: Implication for COVID-19.
34397350 2021. Isotretinoin Meets COVID-19: Revisiting a Fragmented Paradigm.
34396374 2021. Zinc thiotropolone combinations as inhibitors of the SARS-CoV-2 main protease.
34370655 2021. Anti-Diabetic Drugs GLP-1 Agonists and DPP-4 Inhibitors may Represent Potential Therapeutic Approaches for COVID-19.
34337734 2021. Plasma convalescent decrease mortality in COVID-19 patients: a systematic review and meta-analysis.
34338121 2021. Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness.
34230217 2021. Rapid resolution of COVID-19 after faecal microbiota transplantation.
34407027 2021. Anti-Inflammatory Dietary Considerations for Reducing Severity of COVID-19 Infections: An Interview With Arnold Eiser, MD.
34376138 2021. Can Antimalarial Phytochemicals be a Possible Cure for COVID-19? Molecular Docking Studies of Some Phytochemicals to SARS-CoV-2 3C-like Protease.
34455971 2021. DAMPening Severe COVID-19 with Dexamethasone.
34448693 2021. Tocilizumab: A retrospective multi-center cohort study of critically ill patients with COVID-19.
34431178 2021. Can treatment with teicoplanin improve the prognosis of COVID-19 patients?
34347990 2021. Rationalization of Mushroom-Based Preventive and Therapeutic Approaches to COVID-19: Review.
34330344 2021. The 100(th) anniversary of bacille Calmette-Guerin (BCG) and the latest vaccines against COVID-19.
34378474 2021. Insights into the modulation of the interferon response and NAD(+) in the context of COVID-19.
34418270 2021. 2-Deoxy-d-glucose exploits increased glucose metabolism in cancer and viral-infected cells: Relevance to its use in India against SARS-CoV-2.
34413210 2021. High-Dose Nitric Oxide From Pressurized Cylinders and Nitric Oxide Produced by an Electric Generator From Air.
34429051 2021. Systematic Review on Treatment Trials of Tocilizumab- A Repurposing Drug Against COVID-19.
34355175 2021. A review of the latest research on M(pro) targeting SARS-COV inhibitors.
34382564 2021. Corticosteroids in critical COVID-19: Are all corticosteroids equal?
34392751 2021. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations.
34344822 2021. WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access.
34353930 2021. WHO relaunches global drug trial with three new candidates.

34431004 2021. Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials.
34364698 2021. Response to Letter Regarding Article, "Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial".
34362568 2021. Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use.
34407441 2021. Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial.
34418550 2021. Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis.
34411900 2021. Camphor, Artemisinin and Sumac Phytochemicals as inhibitors against COVID-19: Computational approach.
34403938 2021. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2.
34388463 2021. Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2.
34358993 2021. Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2.
34340125 2021. Potential inhibitors of the main protease of SARS-CoV-2 and modulators of arachidonic acid pathway: Non-steroidal anti-inflammatory drugs against COVID-19.
34333227 2021. Tracking the interaction between single-wall carbon nanotube and SARS-Cov-2 spike glycoprotein: A molecular dynamics simulations study.
34332351 2021. Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis.
34332348 2021. Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum.
34450382 2021. Computer-aided prediction of inhibitors against STAT3 for managing COVID-19 associated cytokine storm.
34457214 2021. An overview of potential inhibitors targeting non-structural proteins 3 (PL(pro) and Mac1) and 5 (3CL(pro)/M(pro)) of SARS-CoV-2.
34426763 2021. Docking-generated multiple ligand poses for bootstrapping bioactivity classifying Machine Learning: Repurposing covalent inhibitors for COVID-19-related TMPRSS2 as case study.
34426762 2021. Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery.
34401047 2021. Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2.
34461322 2021. Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial.
34353339 2021. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients.
34345826 2021. Interleukin-7 Reverses Lymphopenia and Improves T-Cell Function in Coronavirus Disease 2019 Patient With Inborn Error of Toll-Like Receptor 3: A Case Report.
34336280 2021. The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences.
34430093 2021. Efficacy of Bamlanivimab in Reducing Hospitalization and Mortality Rates in COVID-19 Patients in a Rural Community.
34408945 2021. Teleophthalmology and Artificial Intelligence As Game Changers in Ophthalmic Care After the COVID-19 Pandemic.
34377611 2021. People Who Chose the Preventive Natural Bioenergetics (NB) COVID-19 Treatment Safely Experienced a Significant Reduction of COVID-19 Symptoms Compared to the General Population.
34448061 2021. Phytomolecules Repurposed as Covid-19 Inhibitors: Opportunity and Challenges.
34461565 2021. Updated pharmacological effects of Lonicerae japonicae flos, with a focus on its potential efficacy on coronavirus disease-2019 (COVID-19).
34397605 2021. The role of immunomodulatory medications in the treatment of COVID-19.
34450519 2021. Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response.
34418758 2021. Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection.
34334801 2021. Tofacitinib Use in Adults with Chronic Inflammatory Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: What Is Known So Far?
34352992 2021. Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).
34352990 2021. Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).
34364302 2021. Does Vitamin D have a role to play in Covid-19 in the dexamethasone era?
34340050 2021. Spurious undermining of the adjuvant role of vitamin D in COVID-19.
34461139 2021. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression.
34398433 2021. Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study.
34375445 2021. CONVALESCENT plasma for COVID-19: A meta-analysis of clinical trials and real-world evidence.
34347191 2021. Effectiveness of favipiravir in COVID-19: a live systematic review.
34350584 2021. Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity.
34355795 2021. A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model.
34438124 2021. Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
34379196 2021. An observational study for appraisal of clinical outcome and risk of mother-to-child SARS-CoV-2 transmission in neonates provided the benefits of mothers' own milk.
34367094 2021. An Ensemble Matrix Completion Model for Predicting Potential Drugs Against SARS-CoV-2.
34354677 2021. Combining SARS-CoV-2 Proofreading Exonuclease and RNA-Dependent RNA Polymerase Inhibitors as a Strategy to Combat COVID-19: A High-Throughput in silico Screening.
34458322 2021. DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2.
34368228 2021. The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge.
34421521 2021. Commentary: Management of Intractable Pain in Patients With Implanted Spinal Cord Stimulation Devices During the COVID-19 Pandemic Using a Remote and Wireless Programming System.
34395500 2021. Inverse Association Between the Mediterranean Diet and COVID-19 Risk in Lebanon: A Case-Control Study.
34367956 2021. Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients.
34456720 2021. Efficacy and Safety of Qingfei Paidu Decoction for Treating COVID-19: A Systematic Review and Meta-Analysis.
34456719 2021. Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen-Case Series Report.
34434105 2021. Case Report: Can Inhaled Adenosine Attenuate COVID-19?
34421592 2021. Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics.
34421587 2021. The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models.
34421581 2021. Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis.
34408654 2021. Chloroquine and Hydroxychloroquine Use During Pregnancy and the Risk of Adverse Pregnancy Outcomes Using Real-World Evidence.
34393789 2021. Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19.
34354592 2021. Medicinal Plants Used for Treating Mild Covid-19 Symptoms Among Thai Karen and Hmong.
34335247 2021. Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review.
34335237 2021. Potentials of Antitussive Traditional Persian Functional Foods for COVID-19 Therapy(dagger).
34408665 2021. Auricular Neuromodulation for Mass Vagus Nerve Stimulation: Insights From SOS COVID-19 a Multicentric, Randomized, Controlled, Double-Blind French Pilot Study.
34406858 2021. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
34390285 2021. Association between inhaled corticosteroid use and COVID-19 outcomes.
34396612 2021. Combination of natural antivirals and potent immune invigorators: A natural remedy to combat COVID-19.
34426525 2021. DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 M(pro) inhibitors.
34417349 2021. SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
34413211 2021. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
34333809 2021. An in silico scientific basis for LL-37 as a therapeutic for Covid-19.
34353215 2021. COVID-19 and early human milk lactoferrin.
34436783 2021. Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission.
34427934 2021. Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19.
34424078 2021. Alectinib, COVID-19 and favipiravir.
34455688 2021. Association of prehospital antiplatelet therapy with survival in patients hospitalized with COVID-19: A propensity score-matched analysis.
34433301 2021. 5alpha-Reductase Inhibitors Are Associated with Reduced Risk of SARS-CoV-2 Infection: A Matched-Pair, Registry-Based Analysis.
34358533 2021. Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technology.
34365955 2021. Structural bioinformatics used to predict the protein targets of remdesivir and flavones in SARS-CoV-2 infection.
34408089 2021. SARS-CoV-2 Antibodies in Breast Milk After Vaccination.
34399430 2021. Candidate Psychotropics against SARS - CoV - 2: A Narrative Review.
34423724 2021. Nebulization with alkaline hipertonic ibuprofen induces a rapid increase in platelets circulating in COVID-19 patients but not in healthy subjects.
34344196 2021. Inhalation von Budesonid reduziert die Wahrscheinlichkeit einer schweren COVID-19-Erkrankung.
34347106 2021. Steroids use in non-oxygen requiring COVID-19 patients: a systematic review and meta-analysis.
34341590 2021. Coronavirus disease-19 Pandemic and Vitamin D: So Much for so Little?
34416823 2021. Research Status of the Safety and Efficacy of Mesenchymal Stem Cells in the Treatment of COVID-19-Related Pneumonia: A Systematic Review and Meta-Analysis.
34365665 2021. Assessment of the potentially decreased neutralizing activities of intravenous immunoglobulin against future coronavirus variants.
34456266 2021. Preemptive Antibody Therapy for Vaccine Breakthrough SARS-CoV-2 Infection in Immunocompromised Patients.
34388031 2021. Levamisole Therapy in COVID-19.
34355546 2021. NLRP3 inflammasome activation and oxidative stress status in the mild and moderate SARS-CoV-2 infected patients: impact of melatonin as a medicinal supplement.
34387443 2021. Terapiya monoklonal'nymi antitelami bystroprogressiruyushchego i vysokoaktivnogo rasseyannogo skleroza v epokhu pandemii COVID-19.
34412743 2021. [A multicenter prospective cohort study of Xuebijing injection in the treatment of severe coronavirus disease 2019].

34230907 2021. All-Atom Simulations and Free-Energy Calculations of Antibodies Bound to the Spike Protein of SARS-CoV-2: The Binding Strength and Multivalent Hydrogen-Bond Interactions.
34212739 2021. Opinion and uptake of chloroquine for treatment of COVID-19 during the mandatory lockdown in the sub-Saharan African region.
34251904 2021. Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
34251903 2021. Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
34242743 2021. Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy.
34310217 2021. Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs.
34310212 2021. Renal and Hepatic Toxicity Analysis of Remdesivir Formulations: Does What Is on the Inside Really Count?
34252308 2021. Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola.
34200327 2021. Green Tea Polyphenol Catechins Inhibit Coronavirus Replication and Potentiate the Adaptive Immunity and Autophagy-Dependent Protective Mechanism to Improve Acute Lung Injury in Mice.
34202330 2021. The Relevance of Plant-Derived Se Compounds to Human Health in the SARS-CoV-2 (COVID-19) Pandemic Era.
34207391 2021. Electron Donor-Acceptor Capacity of Selected Pharmaceuticals against COVID-19.
34204362 2021. Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19.
34303749 2021. Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase.
34265358 2021. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2.
34433900 2021. Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants.
34359926 2021. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
34393329 2021. Metal doped fullerene complexes as promising drug delivery materials against COVID-19.
34352160 2021. New Pyrazine Conjugates: Synthesis, Computational Studies, and Antiviral Properties against SARS-CoV-2.
34382337 2021. Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIbeta) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses.
34366052 2021. Caution When Comparing the Impact of Corticosteroids in COVID-19.
34429982 2021. Favipiravir-induced nephrotoxicity in a patient with COVID-19: A case report.
34401155 2021. Severe sinus bradycardia associated with favipiravir in a COVID-19 patient.
34364853 2021. Previous vitamin D status and total cholesterol are associated with SARS-CoV-2 infection.
34436742 2021. Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients.
34391936 2021. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility.
34352390 2021. BTK inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A systematic review.
34461289 2021. Immunomodulation and immunotherapeutics of COVID-19.
34425240 2021. Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients.
34358296 2021. Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease.
34357386 2021. Effect of ivermectin in the treatment of COVID-19: A trial sequential analysis highlighted the requirement of additional randomized controlled trials.
34379740 2021. Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
34426799 2021. Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity.
34396087 2021. Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia.
34438068 2021. Tocilizumab for coronavirus disease 2019 in pregnancy and lactation: a narrative review.
34353669 2021. Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study.
34330515 2021. Nutrition guidelines for critically ill adults admitted with COVID-19: Is there consensus?
34330513 2021. Dietary supplements and herbal medicine for COVID-19: A systematic review of randomized control trials.
34330508 2021. Influence of nutritional assistance on mortality by COVID-19 in critically ill patients.
34330507 2021. Low vitamin D levels and increased neutrophil in patients admitted at ICU with COVID-19.
34330500 2021. Evaluation of nutritional status in pediatric patients diagnosed with Covid-19 infection.
34330494 2021. Nutrition risk prevalence and nutrition care recommendations for hospitalized and critically-ill patients with COVID-19.
34330492 2021. Impact of vitamin D deficiency on COVID-19.
34437013 2021. Chloroquine Ingestion to Prevent SARS-CoV-2 Infection: A Report of Two Cases.
34359331 2021. Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone.
34339864 2021. Advances in the computational landscape for repurposed drugs against COVID-19.
34374967 2021. Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
34339037 2021. NSAIDs and COVID-19: A Systematic Review and Meta-analysis.
34453691 2021. Reply to Zhang and Zhu "MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19".
34453690 2021. Comment on: "MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19".
34419925 2021. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum.
34405140 2021. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE).
34338634 2021. The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates.
34346827 2021. Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody.
34396354 2021. COVID-19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use.
34396353 2021. COVID-19 and Progesterone: Part 1. SARS-CoV-2, Progesterone and its potential clinical use.
34375576 2021. Vitamin D levels in children with COVID-19: a report from Turkey.
34367380 2021. Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks.
34323632 2021. Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis.
34339547 2021. Elevated INR in a COVID-19 patient after concomitant administration of favipiravir and warfarin: A case report.
34381216 2021. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis.
34279840 2021. Curcumin and Piperine in COVID-19: A Promising Duo to the Rescue?
34279839 2021. Cinnamon: A Promising Natural Product Against COVID-19.
34279838 2021. Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).
34279837 2021. COVID-19, Coenzyme Q10 and Selenium.
34279836 2021. Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review.
34225580 2021. Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.
34216205 2021. Consequences of rush to emergency use authorization of bamlanivimab.
34196543 2021. Protein Engineering in the Design of Protein-Protein Interactions: SARS-CoV-2 Inhibitors as a Test Case.
34227154 2021. Accelerated stability study of the ester prodrug remdesivir: Recently FDA-approved Covid-19 antiviral using reversed-phase-HPLC with fluorimetric and diode array detection.
34301158 2021. Molecular docking and dynamics study to explore phytochemical ligand molecules against the main protease of SARS-CoV-2 from extensive phytochemical datasets.
34196258 2021. Ibuprofen and COVID-19 disease: separating the myths from facts.
34370620 2021. Association of 25-Hydroxyvitamin D Level with COVID-19-Related in-Hospital Mortality: A Retrospective Cohort Study.
34450619 2021. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.
34431263 2021. Clinical Study of Use of Remdesivir and Tocilizumab in Severely Ill COVID-19 Patients.
34431262 2021. Post COVID-19 Mucormycosis in the Second Wave-Realities, Uncertainties and Myths.
34380185 2021. Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility.
34370631 2021. Quantitative structure-activity relationships, molecular docking and molecular dynamics simulations reveal drug repurposing candidates as potent SARS-CoV-2 main protease inhibitors.
34370622 2021. Polypharmacology of some medicinal plant metabolites against SARS-CoV-2 and host targets: Molecular dynamics evaluation of NSP9 RNA binding protein.
34348081 2021. Flavan-based phytoconstituents inhibit Mpro, a SARS-COV-2 molecular target, in silico.
34459720 2021. Ebselen suitably interacts with the potential SARS-CoV-2 targets: an in-silico approach.
34455933 2021. Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase.
34455932 2021. In silico screening of FDA approved drugs against ACE2 receptor: potential therapeutics to inhibit the entry of SARS-CoV-2 to human cells.
34448684 2021. MD simulation and MM/PBSA identifies phytochemicals as bifunctional inhibitors of SARS-CoV-2.
34431452 2021. Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: in silico molecular docking and dynamic simulation studies.
34431451 2021. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from Aegle marmelos deciphered using molecular docking analysis.
34427179 2021. In silico study on spice-derived antiviral phytochemicals against SARS-CoV-2 TMPRSS2 target.
34424815 2021. In silico screening of Pueraria tuberosa (PTY-2) for targeting COVID-19 by countering dual targets M(pro) and TMPRSS2.
34424151 2021. Venetoclax: a promising repurposed drug against SARS-CoV-2 main protease.
34415218 2021. Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study.
34338602 2021. In silico analysis of marine natural product from sponge (Clathria Sp.) for their activity as inhibitor of SARS-CoV-2 Main Protease.
34405765 2021. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19.
34396938 2021. Computational study for identifying promising therapeutic agents of hydroxychloroquine analogues against SARS-CoV-2.
34379031 2021. Designing Self-Inhibitory fusion peptide analogous to viral spike protein against novel severe acute respiratory syndrome (SARS-CoV-2).
34341313 2021. QTc prolongation and mortality in SARS-2-CoV-infected patients treated with azithromycin and hydroxychloroquine.
34403259 2021. Discovery of Novel Small-Molecule Inhibitors of SARS-CoV-2 Main Protease as Potential Leads for COVID-19 Treatment.
34387990 2021. Machine Learning Models Identify Inhibitors of SARS-CoV-2.
34383045 2021. Letter to the Editor from Viola Viola: "Calcifediol treatment and COVID-19-related outcomes".
34431552 2021. Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis.
34416093 2021. Frequency of COVID-19 in acne patients treated with oral doxycycline: A retrospective cross-sectional comparative study.
34405764 2021. A Combination of alpha-Lipoic Acid (ALA) and Palmitoylethanolamide (PEA) Blocks Endotoxin-Induced Oxidative Stress and Cytokine Storm: A Possible Intervention for COVID-19.
34397203 2021. COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients.
34353257 2021. Nature-derived hit, lead, and drug-like small molecules: Current status and future aspects against key target proteins of Coronaviruses.
34353251 2021. The Promising Enzymes for Inhibitors Development against COVID-19.
34407336 2021. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
34407335 2021. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
34407334 2021. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
34375967 2021. A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2.
34417590 2021. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
34400835 2021. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
34363064 2021. Coronapod: Ivermectin, what the science says.
34341573 2021. Flawed ivermectin preprint highlights challenges of COVID drug studies.
34369338 2021. Vitamin D and acute and severe illness - a mechanistic and pharmacokinetic perspective.